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TO MY FAMILY
SUMMARY
The serum of tumour-bearing rats has been tested to determine 
if there is any protein shedding from the plasma membrane of the 
tumour cells. Both immunological and enzymological approaches have 
been employed. Methods for isolation of plasma membrane fragments 
for two different hepatomas have been developed. Plasma membrane 
fragments from the less rapidly growing (WBA) hepatoma are recovered 
in two distinct size classes which, it is suggested, derive from two 
distinct areas of the plasma membrane which have been distinguished 
by electron microscopy. Plasma membranes from the more rapidly 
growing (UA) hepatoma appeared much more uniform both in morpho­
logical appearance and in cell fractionation experiments. An 
antiserum has been prepared against purified plasma membrane 
fragments from the ’UA1 hepatoma. The reaction of this antiserum 
has been examined by crossed immunoelectrophoresis and the various 
proteins characterised by comparison with the reaction of the sera 
with anti-(rat serum) and antiserum prepared against the serum of 
tumour-bearing rats and normal liver plasma membrane. The results 
did not show extensive release of material from the tumour plasma 
membrane into the serum, although evidence was obtained for a complex 
containing material deriving from tumour plasma membrane together 
with host serum proteins.
Enzymological methods have been used to study the 5 ’-nucleotidase 
and alkaline phosphatase enzymes in plasma membrane fragments and in 
serum. Evidence was obtained that the apparent 5 ’ -nucleotidase 
activity of normal rat serum is largely due to a non-specific phosphatase. 
This was also suggested by gel filtration of serum on Sephadex G-200.
Gel filtration of the serum of tumour-bearing rats did, however, give 
evidence for the presence of a very high molecular weight complex 
which contains 5’-nucleotidase but with little if any alkaline 
phosphatase activity. This would be consistent with the complex 
deriving from the surface of tumour cells.
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. .CHAPTER ONE
INTRODUCTION
INTRODUCTION
The plasma membrane, which forms the surface of the animal cell, 
plays an important function in interactions between cells, in the 
response of the cells to the external environment and in the recognition 
of neighbouring cells. The immunological system of animals has the 
ability to reject any 'foreign1 material to which it may have been 
exposed. It has been suspected that animals are capable of recognising 
at least some tumours as 'foreign' and should therefore be capable of 
rejecting them. However, many tumours grow and spread in the. body.
This is partly because the tumour-specific antigens are not strongly 
antigenic and the degree of immunity developed is insufficient to cause 
the rejection of a rapidly growing tumour, but the lack of rejection 
could also be explained by some material in the host, organism which 
interacts with its defence mechanism. One suggestion is that so-called 
blocking antigens bind to circulating antibodies and so prevent them 
from reaching the site of the tumour. The interaction between 
tumour-specific antigens and antibodies will occur on the outer 
surface of the plasma membrane.
The discussion -in the preceding paragraph shows clearly that it 
is important for cancer biochemists to understand the structure and 
function of the plasma membrane. Moreover, as the majority of the 
proteins present on the outer surface of the plasma membrane are 
glycoproteins, they contain carbohydrate attached by covalent linkages 
to the polypeptide chains. I shall discuss briefly the biosynthesis 
of glycoproteins and how these are transferred to the outer surface of 
the plasma membrane, before discussing the changes in the cell surface 
between cells in normal and neoplastic tissues.
1-1 PLASMA MEMBRANE STRUCTURE AND FUNCTIONS
The plasma membrane foims the barrier between the interior of 
the cell and the environment, and is the site at which external 
regulators such as hormones act on the cell. On examination under 
the electron microscope, the plasma membrane appears to be a three- 
layered structure with a total thickness of 75-100 X, which is 
referred to as a 'unit membrane' (Novikoff, 1976). The structure 
and function of the plasma membrane has been recently reviewed by 
De Pierre and Kamovsky (1973), Harrison and Lunt (1975) and .,
Finean et al. QL978). The fundamental function of the plasma membrane 
is that of protection. Thus the cell can maintain a constant 
internal environment, irrespective of changes that may occur outside. 
The plasma membrane has associated with it a range of 'transfer 
systems', which enable molecules to pass through the membrane in a 
specific manner. So the cell membrane, while protecting the cell 
from a variable external environment, allows selective communication 
with the exterior. Arrangements must be made for the controlled 
passage of nutrients into the cell, and;.the removal of waste products 
from it. The plasma membrane acts as a passive diffusion barrier to 
charged and large molecules and in addition carries out facilitated 
diffusion, active transport, endocytosis (pinocytosis and 
phagocytosis) and exocytosis. Finally, the plasma membrane may be 
involved in such sophisticated processes as immunological defence 
and information storage.
The plasma membrane contains lipids, proteins and carbohydrates. 
The carbohydrate is covalently bonded either to lipid or to protein,; 
and the carbohydrate-containing molecules will be considered as 
lipids or proteins as appropriate.
hydrophilic head group within the molecule. Mast of the polar lipids 
of cells are, in fact, localised in the membranes. Membrane lipids 
are organised as a bilayer. Membrane proteins show a complex 
distribution, some being attached to one or the other surface of a 
membrane and others either partially penetrating or passing right 
through a lipid bilayer. There are two classes of polar lipids, 
phospholipids and .glycolipids.' - - - - The lipids are arranged so
that the long aliphatic chains are located within the interior of 
the membrane, and all the hydrophilic head groups face the aqueous 
environment.
Membrane proteins have been classified into two categories 
based on their ease of dissociation from the membrane, namely 
extrinsic proteins (also referred to as peripheral or membrane- 
associated proteins) and intrinsic (or integral) proteins. Currently 
accepted models of membrane structure distinguish between the 
locations of extrinsic and intrinsic membrane proteins. Both are 
believed to be globular proteins which are positioned differently 
relative to the lipid bilayer. Intrinsic proteins penetrate, and 
occasionally cross, the hydrophobic interior of the membrane, 
whereas extrinsic proteins are believed to be associated with the 
polar head groups of the lipid bilayer.
1-2 BIOSYNTHESIS AND SECRETION OF CELL GOAT GLYCOPROTEIN
At the present time, there is great interest in the biosynthesis 
and function of membrane glycoproteins, particularly those associated 
with the cell surface, because evidence is accumulating that these 
compounds may be involved in cell-cell interactions. There are many 
reviews dealing with the biosynthesis of glycoprotein (e.g. Gottschalk, 
1966; Nigam and Cantero, 1973; Lennarz, 1975). Glycoproteins are 
defined as protein-carbohydrate complexes in which oligo- or poly­
saccharides are joined by covalent linkage to specific amino acids of
proteins. The carbohydrate portion contains acidic or basic 
sugars (glucosamine, galactosamine, or sialic acid), and neutral 
sugars (galactose, mannose, or fructose).
The polypeptide components of glycoproteins are synthesised 
on ribosomes, bound to the endoplasmic reticulum (Redman and 
Cherian, 1972). After their completion, the carbohydrate side 
chains are added (Spiro, 1969) in a stepwise manner to the 
polypeptide chains as they migrate through the endoplasmic 
reticulum-Golgi complex system (Schachter et aL, 1970). The 
Golgi apparatus plays an important role in the secretion of 
proteins and polysaccharides. The completed glycoprotein is then 
rapidly transferred to the outer surface of the plasma membrane 
to be added to the 'cell coat' (Bennett and Leblond, 1970).
Both N-acetylglucosamine and mannose are added to the 
polypeptide chain in the rough endoplasmic reticulum. It appears 
that mannose incorporation occurs immediately after the nascent 
protein is released from the polysomes, and that the released 
glycoprotein remains attached to the membrane of the endoplasmic 
reticulum (Redman and Cherian, 1972). When the newly formed 
glycoproteins pass to the smooth endoplasmic reticulum and the 
Golgi apparatus, other moieties of N-acetylglucosamine and 
galactose are incorporated into the glycoprotein side chains.
At this point, the glycoprotein leaves the membrane 
and is found, together with albumin, within
the cistemae of the smooth microsomes (Redman and Cherian, 1972).
A more detailed account of the biochemistry of glycoproteins can . 
be found in "Glycoproteins" by Gottschalk (1972), as well as the 
review by Hughes (1975).
1-3 ALTERATIONS OF THE PLASMA MEMBRANE IN NEOPLASIA
Malignant tumours are characterised by abnormalities in the 
regulation of their growth and by their invasiveness. Therefore 
alterations in the cell surface membrane could be a crucial event 
in the transformation of normal cells into tumours. Hence, there 
have been, for many years, extensive studies on the surface of normal 
and tumour cells (e.g. Coman, 1960; Abercrombie and Ambrose, 1962; 
Emmelot and Benedetti, 1967; Wallach, 1969; Hakamori, 1973;
Baldwin, 1976; Weinstein et al., 1976). A number of differences have 
been noted, and may be classified as follows:
(a) Alterations in cellular contact.
(b) Alterations in surface charge.
(c) Alterations in permeability.
(d) Alterations in the immunological properties of the cell 
surface.
(a) Alterations in cellular contact
Ci) The alterations in intercellular adhesion
There is evidence that, in many tumours, the adhesion of 
neoplastic cells to each other and to normal cells is defective. 
Coman (.1944) interpreted this evidence in terms of the decreased
'mutual adhesiveness'of the neoplastic cells, and correlated it with 
the impairment of the capacity of the cancer cell to bind calcium 
(Coman, 1953) . He concluded (Coman, 1960) that, during the 
transformation of a normal to a neoplastic cell, an alteration of 
the external membrane takes place. Wallach (1969) also discusses 
changes in cellular adhesiveness during neoplastic conversion and 
quotes evidence showing that both increased and decreased mutual 
adhesiveness can occur. Intercellular adhesion in normal tissues as 
well as tumours is clearly a multifactorial process (Curtis, 1973), , 
but there are nice reviews which deal with the topic (e.g. Curtis, 
1973; Weinstein et al., 1976).
(ii) Contact inhibition of movement
This well known effect was extensively described by Abercrombie 
and Heaysman (1953) and Abercrombie and Ambrose (1958). They observed 
that cell locomotion appears to be inhibited when cells collide with 
their neighbours. Stoker (1967) has concluded that contact 
inhibition is commonly abnormal in tumour cells and discussed the 
fact that the defect appears very early in the neoplastic conversion 
of various cells by oncogenic viruses. However, some tumour cells, 
which are not inhibited by association with like cells, are inhibited 
by contact with normal cells or different tumour cells (Stoker, 1967). 
He explains these diverse observations by proposing that contact 
inhibition requires both a transmitter and a receptor and that the 
tumour cell can receive a specific message leading to contact 
inhibition but that it cannot send this message to a cell of its own 
kind.
Contact inhibition of movement has been given a simple definition
by Abercrombie (1970) as the stopping of the continued locomotion of 
a cell in the direction which has produced a collision with another 
cell. Weinstein et al. (1976) mention that many strains of malignant 
cells in culture are relatively insensitive to contact inhibition. 
However, this characteristic cannot be considered an invariant 
property of all malignant cells. More details and some theories 
attempting to identify a simple mechanism of contact inhibition of 
movement can be found in the review of Weinstein et al. (1976).
(iii) Electrical coupling and molecular transfer
It has been well established that electrical connections can 
occur between individual cells of various tissues (Loewenstein et al., 
1965), including hepatocytes of normal or regenerating liver (Penn, 
1966; Loewenstein and Penn, 1967). However, Loewenstein and his 
colleagues provided the first evidence of a defect in low-resistance 
coupling in solid tumours. They made electrical measurements on 
carcinomas in the liver (Loewenstein and Kanno, 1967), thyroid 
(Jamakosmanovic and Loewenstein, 1968), and stomach (Kanno and 
Matius, 1968), and found an absence of electrical coupling. 
Loewenstein proposed as the basis of these observations and 
theoretical considerations that a genetically determined interruption 
of junctional communication may be one of many causes of cancerous 
growth. Later, Sheridan (1970) succeeded in demonstrating electrical 
coupling between some tumour cells. This was confirmed by McNutt 
et al. (1971).
Communication between adjacent cells apparently acts as an 
important mechansim of metabolic control. Stoker (1967) showed that 
the defective nucleic acid metabolism of a mutant of polyoma
transformed cells can be corrected by cell contact with normal 
(unaffected) cells. This suggests that some undefined substance 
from the unaffected cell is passed to the mutant during cell contact.
(b) Alterations in surface charge
The interaction between individual cells has long been considered 
to depend on the charge density on cell surfaces (Wallach, 1969). 
Therefore many investigators have attempted to explain the altered 
contact behaviour of neoplastic cells by abnomnalities of cell surface 
charge. However, as pointed out by Wallach (1969), no studies have 
been made correlating charge density, adhesiveness and contact 
inhibition. A number of workers (e.g. Forester et al., 1964) have 
suggested that the increased net surface charge of many neoplastic 
cells is due to an increased content of sialic acid (N-acetyl- 
neuraminic acid) in the plasma membrane. Mayhew (1966) has presented 
evidence that cell-surface sialic acid is synthesised during the late 
G2 and mitotic phases of the cell cycle. Rosenberg and Einstein 
(1972) have confirmed this observation and suggested that an 
alternative interpretation is that the natural rate of destruction of 
surface sialic acid is decreased.
Cc) Alterations in permeability
Alterations in the permeability of the plasma membrane of animal 
cells may play an important role in the regulation of cell growth and 
multiplication (Pardee, 1964; Sanford, 1967; Foster and Pardee, 1969; 
Weinstein et al., 19/6). There is evidence that the plasma membrane 
of tumour cells has abnoimal permeability to certain intracellular 
enzymes, especially acid hydrolases (i.e. lysosomal) (see review by
Poole, 1973). It has been suggested that this phenomenon is closely 
related to the ability of many tumours to metastasise and to invade 
and destroy normal tissues (e.g. Carr, 1963; Weiss and Holyoke,
1969; Poole, 1973). The presence in the extracellular environment 
of tumours, of many normally intracellular enzymes, could be 
attributed to moribund or damaged tumour cells. However, in vitro 
studies on a variety of malignant cells have shown that viable cells 
may release large amounts of enzyme, apparently by active secretion 
in some cases (Poole, 1973). The mechanisms for this release are 
not yet known.
(d) Alterations in the immunological properties of the cell surface
The abilities to invade and metastasise constitute the lethal 
properties of malignant neoplasia and are the two clinical features 
that distinguish malignant neoplasia (cancer) from neoplasia in 
general. A non-invasive, non-metastasising neoplasm, even if 
rapidly growing, is clinically benign, not malignant. For neoplastic 
cells to form an invasive, metastatic tumour, they may need to overcome 
the disadvantage of their unique antigenicity, that is, they must 
avoid or escape from the host immune defences (Wallach, 1975).
Immunological changes of the plasma membrane associated with 
neoplasia fall, into three categories as follows:
Ci) Tumour specific antigens 
Cii) Embryonic antigens 
Ciii) Antigen deletion
(i) Tumour specific antigens
Since the observation by Foley (1953) that tumours possess 
antigens which can elicit an immune response from the host, there 
have been extensive studies on the nature of these ' tumour- 
rejection’ antigens (Wallach, 1969; Baldwin, 1973). The 
tumour-specific antigens detected in many carcinogen-induced tumours 
have been identified by their capacity to elicit immune reactions 
either in the original host against primary growths or in syngeneic 
hosts against transplanted tumour cells (Baldwin, 1973).
Tumour-associated rejection antigens are almost certainly 
located within the cell surface membrane. Perlmann and Holm (1969) 
have mentioned that it is difficult to conceive how intracellular 
antigens could operate to produce rejection reactions, because the 
tumour cell membrane is largely impermeable to antibody. The 
importance of cell membrane-associated antigens has been more 
directly demonstrated by in vitro studies of the cytotoxicity of 
immune serum or sensitised lymphocytes for culture tumour cells 
(Baldwin, 1973), although the mode of action of sensitised lympho­
cytes is still not yet clearly defined. The general opinion is that 
cell-mediated immunity is of primary importance in the early response 
of the body to a tumour.
(ii) Embryonic antigens
A further group of antigens found in tumours but not in normal 
adult cells is due to genes normally expressed during embryonic 
differentiation but repressed in adult life (time-displaced-antigens). 
Baldwin (1973) has suggested that embryonic antigens found in tumours 
may result from gene depression, which may be either directly or
indirectly attributed to the action of the chemical carcinogen.
These antigens are detectable by immune diffusion methods in soluble 
fractions from hepatoma homogenates and also are present in the serum 
of tumour-bearing hosts, so that they may be viewed as secretory 
products of the tumour cell (see Baldwin, 1973). He has argued that 
the embryonic antigens in rat hepatomas' and. sarcomas are present in 
the cytosol, and are not found on the plasma membrane to any marked 
extent. These findings distinguish the embryonic antigens from the 
tumour-specific antigens which are known not to be present in 
intracellular fractions from hepatomas and sarcomas (Baldwin, 1973).
Ciii) Antigen deletions
The binding of many chemical carcinogens to DNA and ENA has 
been observed (Baldwin, 1973). This may result in mutation leading 
to the production of novel proteins or to the induction or 
repression of ’noimal1 genes. The production of new proteins and 
the induction of embryonic genes has been discussed above, but 
neoplastic transformation may also be accompanied by the loss of: 
organ-specific antigens. While many of these deleted antigens are 
intracellular, rather than plasma membrane components, there is 
evidence that some plasma membrane antigens are lost during 
carcinogenesis. Baldwin (.1973) has suggested that this loss of 
normal plasma membrane antigens may be causally related to the 
appearance of tumour-specific antigens, but it has not been 
established that these ’deleted antigens' are actually lost from 
the plasma membrane. It is possible that the antigens may simply 
be located at some site in the plasma membrane of tumour cells 
that is inaccessible to antibodies.
1-4 BMJNOLOGICAL RESPONSE OF THE HOST TO TUM3UR ANTIGENS
There are two different types of immunological response which 
occur when ’foreign1 antigens enter the body.
(i) Free antibody is synthesised and released into the blood 
and other body fluids. This type of immunological 
response is called a ’humoral response’.
(ii) The second type is ’cell-mediated immunity' by production 
of sensitised (T) lymphocytes which have antibody-like 
molecules on their surface (cell-bound antibody) (see 
Roitt, 1977).
If (T) lymphocytes recognize tumour antigens as foreign, they 
may develop into killer cells and/or they may stimulate other cells 
to become killer cells, both specifically, e.g. by producing 
antibodies that can 'arm' bone marrow-derived (B) lymphocytes and 
macrophages, and nonspecifically by releasing various substances 
that can activate other cells as well as help to destroy the tumour 
by a cytotoxic effect (Hellstrom and Hellstram, 1974).
Immunological recognition of malignant cells is clearly 
important in the tumour-host relation. There is clear evidence that 
many tumours are recognised as ’foreign’ and the neoantigens involved 
have been characterised in a number of animal tumours (Baldwin, 1973; 
Lamon, 1974; Baldwin and Price, 1975). However, it is clear that 
tumour-associated antigens expressed at the cell surface do not 
necessarily function as effective rejection antigens, even though 
they elicit specific immune responses in the tumour-bearing host.
For example, Baldwin and Robins (1976) have pointed out that in
chemically induced tumours, the tumour rejection antigens are often 
characteristic components of individual tumours so that tumour 
immunity is effective only against cells of the immunising tumour.
Several explanations can be proposed to account for the failure 
of tumour-associated cell-surface antigens to mediate tumour 
rejection responses including:
Ci) immunodeficiency of the host;
(ii) sneaking through;
Ciii) alteration in neoantigen expression and/or function;
(iv) abrogation of tumour immunity by host factors.
The concept that tumour-associated antigens may not be 
recognized by the host has proved generally untenable, in view of 
the many studies demonstrating cellular and humoral immune responses 
in tumour-bearing individuals (Hellstrom and Hellstrom, 1974). The 
'sneaking-through' hypothesis implies that a nascent tumour may not 
provide sufficient stimulus to induce an effective immune response, 
so that, when host defences are eventually mobilised, the tumour is 
already of a size that is outside immunological control (Baldwin and 
Robins, 1976).
Tumour cells undoubtedly show considerable variation in the 
degree of neoantigen expression, so that whilst they may provoke an 
effective immunological response, subpopulations of tumour cells may 
not be susceptible to immune rejection reactions. Baldwin and Robins 
(.1976) have explained that this may result from quantitative 
differences between subpopulations of tumour cells in neoantigen 
expression. Alternatively, the defect may be functional, in that,
whilst neoantigens continue to be expressed at the tumour cell 
surface, they are inadequate receptors for rejection reactions 
mediated by sensitised lymphoid cells or antibody. Baldwin and 
Robins 0-976) have shown that one factor important in this respect 
is the degree of integration of tumour antigens in the cell-surface 
membrane. Baldwin et al. 0974) have already indicated that 
embryonic antigens associated with Carcinogen-induced and 
spontaneous rat tumours do not function effectively, if at all, in 
tumour rejection responses; these antigens are poorly integrated 
components of the cell surface, which are readily released on cell 
rupture. The final hypothesis put forward by Baldwin and Robins 
0976) proposes that failure of immune responses in the tumour- 
bearing host to control tumour growth results from the intervention 
of host factors that diminish the effectiveness of cell-mediated 
immunity. These factors may operate independently or in concert to 
abrogate immunological control of an early developing tumour.
Humoral factors modifying cell-mediated immunity in the 
tumour-bearing host
(a) Blocking reactions at the tumour cell surface
Interference with cell-mediated immunity in the tumour bearing 
host may, in certain circumstances, be produced by serum factors 
interacting with and masking neoantigens on tumour cells, so 
preventing their recognition by sensitised lymphoid cells; this has 
been defined operationally as ’blocking1 (Baldwin and Robins, 1976).
(b) Inhibition of lymphoid cell reactivity
An alternative pathway by which serum factors in the tumour- 
bearing host may abrogate cell-mediated immune rejection reactions 
involves specific desensitisation (inhibition) of cytotoxic lymphoid 
cells through interaction with tumour antigen either in the free 
form or as immune complexes.
Circulating tumour antigen and/or immune complexes have been 
implicated in the inhibitory type of response which leads to a 
specific reduction in the reactivity of sensitised lymphocytes, since 
serum activity rapidly decreased in animals rendered tumour-free 
(Robins and Baldwin, 1974; Shellam and Knight, 1974). Robins and 
Baldwin (1974) have provided further support for the concept that 
tumour antigen-containing factors in tumour-bearer serum inhibit 
tumour-immune lymphocyte cytotoxicity by studies on the neutralisation 
of this activity by tumour-specific antibodies. Antibody 
neutralisation of lymphoid cell inhibitory factors in tumour-bearer 
serum leads to the conclusion that circulating tumour-specific 
antigen and/or immune complexes with available antigen receptors are 
involved in these interactions.
1-5 GENERAL METHODS FOR THE ISOLATION OF PLASMA MEMBRANE
FRAGMENTS FROM NORMAL AND NEOPLASTIC TISSUES
The isolation of plasma membrane fractions from either noimal or 
neoplastic tissues has been the subject of several extensive reviews 
CSteek and Wallach, 1970; Eylar and Hagopien, 1971; Warren and Gll ck, 
19.71; Hinton, 1972; De Pierre and Kamovsky, 1973). In any cell
fractionation technique, the aim is to separate a particular cell 
component intact and undamaged. In the case of cell plasma membrane, 
this is impossible since this membrane must be broken in order to 
release the contents of the cell and to obtain plasma membrane free 
from contamination by intracellular membranes. Isolation of plasma 
membrane may conveniently be discussed under five headings:
- the nature of the tissue to be used,
- the selection of markers,
- disruption of the tissue,
- fractionation,
- analysis
(De Pierre and Kamovsky, 1973). In the case of solid tissues such 
as liver, the cells are bound to each other and form junctional 
complexes (tight junctions - zonula occludens, intermediate ’gap1 
junctions - zonula adherens, desmosome junctions - macula adherens). 
These appear to remain intact during homogenisation of the liver, and 
as a result the plasma membrane from the zones containing the complexes 
is released as large sheets, deriving from several adjacent cells
(Hinton et al., 1970), which sediment into the crude nuclear fraction.
Plasma membrane fragments are also recovered in the microsomal 
fraction as vesicles (El-Aaser and Reid, 1969; Wisher and Evans, 1975). 
These possibly derive from regions of the plasma membrane other than 
the junctional complexes.
(al Separation of large sheets of plasma membrane
Mast procedures for the isolation of plasma membrane from solid 
tissues aim at separating the large sheets of membrane,which sediment
in crude nuclear fraction. All the methods for preparing large 
sheets of plasma membrane fragments from liver are based 
on the method of Neville (1960), which was modified by Emmelot and 
his colleagues (Emmelot et al., 1964). This method consists of gentle 
homogenisation in hypotonic NaHC03 (1 iriM) and preparation of a low
speed pellet which is then separated and carefully washed to remove 
mitochondria and other organelles. Strongly hypotonic solutions are 
required in order to lyse the erythrocytes, which otherwise 
aggregate with the membrane (Hinton et al., 1970); the use of such 
solutions prohibits the isolation of other organelles in an intact 
state. A better method for the removal of erythrocytes than 
homogenisation in hypotonic media is perfusion of the tissue in situ 
(Coleman et aL, 1967; Hinton et al., 1970). One can then homogenise 
in isotonic solutions.
In most tumours perfusion is impossible because of the lack of 
a main blood vessel to the tumour. Therefore, Emmelot and his 
colleagues (Emmelot and Bendetti, 1967; Emmelot and Bos, 1969) had 
recourse to very hypotonic solutions for the isolation of plasma 
membrane from hepatomas. However, there are two further problems 
with hepatoma: the first is that the nuclei of many tumour cells are 
extremely fragile, and nucleoprotein gels may prevent separation of 
cell components from homogenates prepared in hypotonic solutions 
(Davydova, 1968; Prospero, 1975). The second problem is that the 
weak intercellular bonds in many tumours result in the tissue 
initially separating into single cells on homogenisation and yielding 
small sheets and vesicles. However, Prospero and Hinton (1973) 
showed that the use of zonal rotors allowed the preparation of highly 
purified plasma membrane from a slowly growing transplanted hepatoma 
and this method has been further developed in this study.
(b) Isolation of plasma membrane vesicles from the microsomal
fraction
Plasma membrane vesicles are very similar in size and density to 
vesicles deriving from other organelles. Because of the difficulty 
of separating such vesiculated plasma membrane directly from 
microsomal fractions, methods have been'developed which depend on 
selectively modifying the density of seme of the vesicles. Kamat 
and Wallach (1965) were the first to attempt the separation of the 
microsomal plasma membrane from the bulk of the microsomes (e.g. the 
endoplasmic reticulum fragments), with Ehrlich ascites carcinoma 
cells as the test material. They subfractionated microsomes by 
isopycnic centrifugation on Ficoll gradients and found the plasma 
membrane at a median density of 1.07. Flotation in sucrose gradients 
has been used to emphasise the difference in the density of hepatic 
plasma membrane vesicles from those deriving from other organelles 
(Touster et al., 1970; Hinton et aL, 1971; Norris, 1973) with varying 
success. Touster et al. (1970) used a discontinuous sucrose density 
gradient buffered with 5 mM tris-HC£, pH 8.0, for preparation of 
microsomal plasma membrane. They recovered the plasma membrane as a 
turbid white band of material of density 1.15 with relative specific 
activities of 51-nucleotidase and phosphodiesterase about twenty;times 
that of glucose-6-phosphatase.
In general, most workers have preferred to isolate plasma 
membrane fragments in the form of sheets rather than as vesicles. 
Prospero (1975) has suggested that is not only because of the difficulty 
of suitably subfractionating microsomal fractions, but probably also 
due to the reliance on morphological as distinct from biochemical 
identification shown by many investigators. The results of those
investigators who have studied the distribution of the plasma membrane 
marker enzymes in the microsomal fraction will be discussed further, 
together with my own results (Chapter IV-1).
1-6 BIOCHEMICAL MARKERS FOR HEPATOMA ORGANELLES
Obviously, when one wishes to isolate one component from a 
mixture, it is necessary to have assays both for that component and 
for other components which may contaminate the preparation. In this 
study, biochemical criteria, i.e. the assay of marker enzymes, have 
been used to identify the various subcellular organelles. The use of 
marker enzymes in tissue fractionation studies has been the subject 
of several recent reviews (e.g. Reid, 1971), while other authors 
(e.g. Steck and Wallach, 1970; Solyom and Trams, 1972; De Pierre 
and Kamovsky, 1973) have discussed the particular use of marker 
enzymes in the isolation of plasma membrane.
As pointed out by Reid (1967, 1971) the marker enzymes which are 
used in the case of normal liver do not necessarily hold true for
marker fc
other tissues, e.g. iin muscles glucose-6-phpsphatjase is not available as a 
endoplasmic reticulum as it is in liver. Similarly the ATPase of the 
plasma membrane is distinct from the ATPase of muscle sarcoplasmic 
reticulum and mitochondria. In general, enzymes reflect the function 
of the tissue. In particular, Prospero (1975) found that markers 
established for normal liver are not necessarily valid for hepatomas 
under standard assay condition.
The enzymes considered in this study as markers for specific 
organelles were:
(i) 5T-nucleotidase for plasma membrane fragments.
(ii) Glucose-6-phosphatase for endoplasmic reticulum.
(iii) Acid phosphatase for lysosomes.
(iv) Succinate dehydrogenase for mitochondria.
(i) 5!-nucleotidase
The location of this enzyme in tumour was examined by a 
cytochemical technique (Fitzsimmons, 1969). An activity was found in the 
plasma membrane, but not in other organelles. He observed that in 
the transplanted hepatoma, the cellular localisation of ■
5*-nucleotidase is similar to that in noimal liver (El-Aaser, 1965).
The distribution of 5 ’ -nucleotidase among hepatoma cell components 
was used by Emmelot and Bos (1969) and Prospero (1975) as a marker 
for the plasma membrane fragments. Consequently, 5’-nucleotidase 
was used in this work as a marker for the hepatoma plasma membrane 
fragments.
(ii) Glucose-6-phosphatase
It has long been known that, after fractionation, this enzyme 
is recovered in the microsomal fraction (e.g. de Duve et al., 1955).
More recently its location in endoplasmic reticulum membranes has 
been shown cytochemically (see Reid, 1967). In the case of hepatoma, 
Fitzsimons (1969) studied the distribution of glucose-6-phosphatase 
activity using cytochemical techniques. He observed that a positive 
reaction is given only by endoplasmic reticulum and nuclear membrane. 
Prospero (1975) investigated the distribution of glucose-6-phosphatase 
activity among subfractions separated from hepatoma mitochondrial 
and lysosomal fractions using an HS zonal rotor. He observed that 
10 mM Na(+) tartrate reduced the activity in the homogenate by 50-60%.
Na(+) tartrate does not inhibit liver glucose-6-phosphatase but does 
inhibit lysosomal acid phosphatase. Hence Prospero (1975) concluded 
that there was, in hepatoma homogenates, significant breakdown of 
glucose-6-phosphate by acid phosphatase. So, in this study glucose-6-^
(pj
assayed in the presence of 10 iriM Na(+) tartrate to inhibit acid 
phosphatase, was used as a marker for the endoplasmic reticulum 
membranes.
(iii) Acid phosphatase
The distribution of acid phosphatase (using 3-glycerophosphate 
as the substrate) is considered a reliable indicator of the 
distribution of lysosomes (De Pierre and Kamovsky, 1973). Burge 
(1973) found that the distribution of acid phosphatase in the hepatoma 
lysosomal fraction parallels that of the other acid hydrolases, and 
concluded that acid phosphatase is a suitable marker for lysosomes. 
Therefore, this enzyme was used during the course of my study to 
determine lysosomal contamination of the plasma membrane preparations.
(iv) Succinate dehydrogenase
This enzyme is the most common mitochondrial marker, de Duve 
(1967) has mentioned that the use of succinate dehydrogenase as a 
marker for mitochondria is extremely well established. A dye (INT) 
is a very convenient acceptor in the assay of this enzyme (Pennington, 
1961). In this study succinate dehydrogenase was used as a marker for 
mitochondria.
1-7 THE AIMS OF THIS STUDY
The plasma menbrane (animal cell surface) plays an important 
function in interactions between cells, in the response of cells to 
the external environment and in the recognition of neighbouring 
cells. The immunological system of animals has the ability to 
reject any strange body to which it may have been exposed. However, 
growing tumours are not rejected although, at least in experimental 
animals, some tumours are recognised as ’foreign1. An important 
factor for the growth and spread of tumours in the body is that the 
tumour-specific antigens are often not strongly antigenic and the 
degree of immunity developed is insufficient to cause the rejection 
of a rapidly growing tumour. A further explanation is that some 
material, in the host organism interacts with its defence mechanisms.
One suggestion is that so-called blocking antigens bind to circulating 
antibodies or lymphocytes and so prevent them from reaching the site 
of the tumour. The interaction between tumour-specific antigens and 
antibodies will occur on the outer surface of the plasma membrane, so 
that one would expect ’blocking factors’ to derive from the tumour 
plasma membrane.
The main objective of this study is to determine whether or not
the plasma membrane is releasing these materials into the blood. I
will describe experiments to show whether a method for isolating
purified plasma membrane sheets from slow growing hepatoma, developed
still
some years ago in this laboratory, is/applicable following progression 
of the tumour, and whether it can be used with another, more 
rapidly growing hepatoma. I will also describe the development of a 
method for isolating plasma membrane vesicles from the microsomal 
fraction of both tumours and the preparation of an anti-(plasma
membrane) antiserum using the purified plasma membrane separated from 
the hepatoma. Immunological techniques are used to investigate the 
antigens common to rat serum and hepatoma plasma and to study other 
changes in serum proteins of tumour-bearing rats. Enzymological 
methods are used to study the enzyme 5-nucleotidase which is a marker 
for plasma membrane fragments and is also present in serum.
Ouchterlony double diffusion techniques are used to find out if there 
is any relation between the 5-nucleotidase in hepatoma plasma menbrane 
and the plasma membrane of noimal rat liver. I have also examined 
the serum of tumour-bearing rats to deteimine whether there is any 
evidence for release of enzymatically active material from .the tumour 
surface. It is hoped that a combination of immunological and 
biochemical methods will give a clearer picture of the extent to which 
tumours shed surface components into the blood stream.
. .CHAPTER .TWO
MATERIALS AND METHODS
II-l MATERIALS
In general, all chemicals were analytical grade, obtained from BDH 
Chemicals Ltd., Koch-Light Ltd., Hopkins and Williams Ltd. or the Sigma 
Chemical Co. Ltd. Distilled water was used in all media, and all pH 
measurements were made at the temperature of use for each solution, e.g. 
for enzyme assay buffers at 37°C.
Tris buffer [ tris - (hydroxymethyl) -aminomethane], activated charcoal 
and bovine serum albumin were obtained from Sigma Chemicals Co. Ltd.,
AMP (adenosine-5’-monophosphoric acid(disodium salt)), G.6.P (glucose-6- 
phosphoric acid(disodium salt)) from BDH, INT [ 2 - -iodophenyl)-3- 
(p-nitrophenyl)-5-phenyl tetrazolium chloride] and EMG 3,3-dimethyl 
glutaric acid were brought from Koch-Light Ltd. Sodium 3-glycerophosphate 
and bis (p-nitrophenyl) -phosphate (disodium salt) were obtained from BDH 
Chemicals Ltd. Mineral water sucrose was bought from Tate and Lyle Ltd. 
Sepharose-4B was obtained from Pharmacia Ltd. (UK). Anti-rat serum was 
obtained from Mercia Diagnostics Ltd (High Wycombe, Hertfordshire). All 
centrifugation was carried out at 4°C in MSE centrifuges.
II-2 ANIMALS AND TUMOURS
The animals used were hooded rats of the University of Surrey strain. 
The hepatomas were transplants from primaries induced, by Drs. E. Reid 
and B.M. Mullock, by feeding L-ethionine to male rats (Reid, 1970). 
Transplantation was by the subcutaneous route. Two distinct hepatomas 
were studied; the faster growing (UA) tumour has a generation time of
2-3 weeks and the slow growing (WDA) tumour a generation time of about
6 weeks.
II-3 CHEMICAL ESTIMATION AND ENZYME ASSAYS
All assay results were corrected for sucrose interference as 
described by Hinton and Dobrota (1969) and Hartman et al. (1974) . In 
general, results were processed using a computer program developed by 
Hinton (unpublished method).
(a) Protein estimation
Protein was assayed by the Autoanalyser adaptation (Schuel and 
Schuel, 1968) of the method of Lowry et al. (1951), ad modified by Hinton 
and Norris (1972). The "high sensitivity" manifold was used for 
measurements of the protein content of all fractions, with bovine serum 
albumin (BSA) standards ranging from 0.01-1 mg/ml.
(b) Enzymes releasing inorganic phosphate
The following enzymes were assayed by measuring the amount of 
phosphate released during the assay:
5-nucleotidase 
Glucos e-6-phospha tas e 
Acid 3-glycerophosphatase 
Alkaline 3-glycerophosphatase 
Adenosine triphosphatase
In general, the assays for phosphatases were carried out as described 
by Prospero et al. (1973). The basic assay system was the same for all 
these enzymes. An aliquot of 0.5 ml of tissue was mixed with 0.4 ml 
buffer containing any necessary activators. The reaction was then 
started by the addition of 0.1 ml of substrate, followed by mixing on a 
Whirlimixer, and incubated at 37°C for a suitable period of time.
Due to the presence of some endogenous phosphate, substrate and 
tissue blanks were always used. Tissue blanks were perfoimed, for each 
fraction, by adding 0.1 ml distilled water instead of the substrate. 
Substrate blanks were done, usually in duplicate, using 0.5 ml distilled 
water in place of the tissue sample. Assays on reference samples 
(homogenate, nuclear fraction, floated material from the whole homogenate 
and microsomal fraction) were noimally done in duplicate.
The reaction was stopped by adding 1.5 ml of 6% w/v TCA 
and after a period at 4°C the precipitated material was spun down. The 
supernatant was assayed for total inorganic phosphate content by an 
automated method (Hinton et al., 1970) adapted from the method of Lowry 
and Lopez (1946). The standards used were sodium dihydrogen orthophosphate 
solutions (0.1 - lpmoles POit/ml), and treated as the samples, e.g. 1.5 ml 
trichloroacetic acid was added per 1 ml of the standard.
The validity of the assays for the following enzymes: alk. PNPPase, 
alk. 3-Gly.Pase and AMPase has been checked for serum samples. The 
linearity of each assay with incubation time was examined to detennine 
the maximum time suitable for the assay (Figure II-l).
Activity of alk. PNPPase was also checked with different substrate 
concentrations, to establish the optimum substrate concentration which 
should be used (Figure II-2).
It was found that the assay, as used previously for tissue fractions, 
was valid for use with serum samples.
(c) Enzymes releasing p-nitrophenol
Enzymes releasing J> -nitrophenol, namely alkaline phosphatase and 
alkaline phosphodiesterase, were assayed by the automated method of Hinton
0.6*
0.3-
30 60 90 120 150
T (min)
0.6
8
T (min)
40
0
0.6-
w
30
FIG. •II-l Linearity o£ the assay of
(a) 51-nucleotidase
(b) alkaline B-glycerophosphatase
(c) alkaline p-nitrophenylphosphatase 
with incubation time
IJUU
0.2
0.1
0
0.01 0.03 0.05 0.1
J> -nitrophenylphosphate M
FIG. II-2 Activity o£ alkaline J)-nitrophenylphosphatase 
in the serum of a normal rat as a function of 
substrate concentration
and Norris (1972). Substrate concentrations were 0.01 M p -nitropheny 1 
phosphate for phosphatase, and 0.01 M bis(jp-nitrophenyl)-phosphate for 
phosphodiesterase.
(d) Succinate dehydrogenase
Succinate dehydrogenase was assayed by the method of Pennington 
(1961). To an aliquot of 0.5 ml of tissue was added 0.25 ml of a 
freshly-prepared 1.5 mg/ml solution of INT [2- (p-iodophenyl) -3- (p-i-nitrophenyl) 
-5-phenyltetrazolium chloride] in 0.5 M phosphate buffer, pH 7.4. The 
reaction was started by the addition of 0.25 ml of 0.3 M sodium succinate, 
pH 7.4, and, after incubation for 10-20 min, the reaction was stopped by
1.5 ml1, of 61 trichloroacetic acid. The red foimazan was extracted into 
4 ml of ethyl acetate which was then separated from the aqueous phase by 
a short spin. The colour of the extracts was measured at 490 nm against 
an ethyl acetate blank. Tissue blanks were determined by substituting 
0.3 M malonate, pH 7.4 for the succinate in the assay medium.
H-4 TISSUE PREPARATION
(a) Rat liver
After killing the animal by cervical dislocation, the liver was 
removed and immersed in ice-cold 0.25 M sucrose containing 5 mM tris-HQ, 
buffer, pH 8. The tissue was weighed and minced with scissors.
Homogenisation was by three strokes of a Potter-Elvehjem homogeniser with 
a pestle rotated at 900 rev/min. The diametric clearance between pestle 
and vessel was 0.33 mm. The homogenate was filtered through a coarse 
sieve to remove any connective tissue fragments.
(b) Tumours
The animals were killed by cervical dislocation and the tumours
rapidly extracted, complete with their capsule, and chilled by imnersion
a fte r  removvng wtcvcstvc, cex\\_ve ■ 
in ice-cold sucrose^ After weighing, the entire tumours were minced
with scissors and homogenised with a Potter-Elvehjem homogeniser. The
homogenate was filtered as described above, small pieces of connective
tissue from the capsule being retained on the filter. The exact weight
of tissue was obtained by subtracting the weight of the retained material
from the weight of the whole tumour.
II-5 ZONAL CENTRIFUGATION
(a) Preparation of density gradients
Sucrose gradients were used in all the experiments with zonal 
rotors described in this study. Sucrose solutions were prepared from a 
stock solution of 2M sucrose. Their concentrations were checked with an 
Abbe refractometer (Bellingham and Stanley Ltd., London) at 20°. Possible 
impurities were removed from the stock solution by stirring with Norit ’A ’ 
activated charcoal (34 g/1) for about 30 min (Steele and Busch, 1967).
The charcoal was removed by filtration through Whatman no.54 filter 
paper.
There were two types of gradient used:
(i) An "exponential" gradient, used in all experiments with the 
H-S zonal rotor.
(ii) A "linear" gradient, used with the B-XIV zonal rotor, which was 
generated with the "double pump” gradient maker described by 
Hinton and Dobrota (1969).
(i) Preparation of exponential gradients
The apparatus used for the preparation of this type of gradient is 
shown in Figure II-3a. Initially 150 ml of 0.35M sucrose (density 1.045 g/ml) 
was placed in the mixing vessel and put on a magnetic stirrer. The 
following sucrose solutions were added:
Gradient H-S Volml
Sucrose 
conc. M
Density
. 'g/ml
The mixing vessel initially contained 150 0.35 1.045
To this was added 300 0.95 1.124
The mixing volume was then reduced to
(by decantation - with the pump switched off)
75 - -
To this was added 200 1.31 1.170
Cushion (by-passing mixing vessel) to fill 
rotor
2.00 1.249
(ii) Preparation of linear gradient
The gradient maker used for this preparation is shown in Figure II-3b. 
A double piston pump with adjustable flow rate on each channel was used 
to prepare the gradients. The mixing vessel, put on a magnetic stirrer, 
initially contained 375 ml of 0.6M sucrose (density 1.077 g/ml).
Liquid was pumped out from the mixing vessel into the zonal rotor at 
40 ml/min, while 2M sucrose was being added at 20 ml/min, until the whole 
solution from the mixing vessel was used. The density of the resulting 
gradient was found to range from 1.077- 1.257. g/ml.
(b) Loading and displacement of the gradients
Linear or exponential gradients, prepared as described above, were 
loaded into the zonal rotor. Usually the refractive index of the 
gradient pumped into the rotor was recorded as a check on the shape of 
the gradient. With the HS rotor, after the exponential gradient had been 
loaded, the sample was injected carefully through the central line of the
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FIG. 11-3 (a) Diagrammatic representation of the exponential gradient
maker
(b) Diagrammatic representation of the double pump gradient 
maker used for the preparation of linear sucrose gradient
feed head. An overlay of 0.08M sucrose was loaded to the centre to 
displace the sample away from the core of the rotor; then the rotor was 
accelerated from the speed of loading (1,200 revs/min) to a high speed 
(9,000 revs/min). With the B-XIV rotor, on the other hand, the sample, 
which was made up in 2M sucrose, was injected to the edge of the rotor 
at the dense end of the linear gradient, and, to serve as a cushion, ZM 
sucrose was pumped immediately after the sample. The speed of the rotor 
during the loading of gradient and the sample was about 2,000 revs/min; 
when loading was completed, the lid of the centrifuge was closed and the 
rotor accelerated to 44,000 revs/min. After centrifugation for the 
required time, the rotor was decelerated to the loading speed and the 
contents unloaded by pumping in 2M sucrose to the edge of the rotor.
II—6 ELECTRON MICROSCOPY
Tissue was prepared for electron microscopy by a procedure 
essentially similar to that of El-Aaser (1965). After rapid removal of 
the tumour from the rats, samples were prepared by chopping the tumour 
into 1 mm cubes on a cooled glass plate. The tissue was first fixed in 
ice-cold 1% glutaraldehyde (Taab Laboratories Ltd.) dissolved in 0.25M 
sucrose buffered with 0.05M sodium cacodylate, pH 7.2, for about 2h.
The blocks of tissue were washed with 0.094 cacodylate, pH 7.4, and then 
immersed in 2% osmic acid (Taab Laboratories Ltd.) for about lh, and 
dehydrated (twice) by 10 min periods of exposure to 10%, 25%, 50%, 75%, 
90% and 100% absolute ethyl alcohol. It was then immersed in propylene 
oxide for 10 min (twice) and in a mixture of propylene oxide + Epon 812 
(Taab Laboratories Ltd.) for 30 min. Then the blocks were embedded in 
Epon and put in the oven for 48 h at 60°C to polymerise the sample.
After that very thin sections were cut, counterstained with alkaline lead
citrate and uranyl acetate and examined using a JEM 100B electron 
microscope.
II-7 PREPARATION OF SEPHADEX GEL COLUMNS
Gels were allowed to swell in excess 0.9% sodium chloride. The 
initial swelling of the gel slurry was performed on a boiling water bath. 
This reduces the number of air bubbles trapped in the slurry as these 
may cause uneven flow rates in the packed columns.
Columns were packed in either vertical glass tubes with a sinter- 
glass disc fused across one end to support the gel or in the special 
Sephadex laboratory columns (Pharmacia, Sweden). The columns were packed 
as recommended by Pharmacia Ltd. The column was filled with the Sephadex 
slurry and gently stirred to remove any air bubbles. The outlet was 
opened and positioned to allow the solvent to flow out slowly while the
o-
remaining slurry was slowly added to the column. The addition of slurry 
was continued until the required bed height was obtained. The upper 
surface of the bed was protected by a circular piece of filter paper. A 
solvent reservoir was connected to the top of the column and the flow 
rate maintained at a rate of approximately 0.35 ml/min.
The void volume of the column was measured by noting the volume of 
effluent between loading Blue Dextran 2000 (Phaimacia) on the top of the 
column and its appearance at the end of the column. The sample solution 
was applied to the top of the column by Pasteur pipette, without 
disturbing the surface of the column. The density of the sample solution 
was increased by the addition of sucrose (about 30 mg/ml). Once the 
sample had loaded the column was filled and connected to an eluent 
reservoir fitted with a constant head device. Fractions were collected
by time, using a timer connected to a fraction collector (Central 
Ignition Co.).
Although the first experiments were carried out using the technique 
above, the majority of separations were performed by upward displacement 
using large column made by my colleague, Dr. B.M. Mullock. The 
columns were prepared as described by Fischer (1969). Columns used for 
upward displacement are more difficult to prepare as air bubbles must be 
rigorously excluded. Hence, it is usual to use each column repeatedly.
To prevent bacterial growth the columns are equilibrated with 0.0021 
hibitane between experiments. Prior to each of my experiments, I washed 
the column extensively with 0.91 NaCl to remove all traces of hibitane.
Total volume (V^ ) of the gel was calculated from the dimensions of 
the column. The void volume (V ) was determined as mentioned above. The 
elution volume (V ) for a specific peak was measured for each sample.
V
Hence the partition coefficient for a particular sample peak between the 
mobile liquid phase and the stationary gel phase may be determined from 
the formula:
II—8 GEL ELECTROPHORESIS
For all immunoelectrophoresis techniques described in this study,
1% w/v agarose in 0.044M-barbitone buffer, pH 8.6, was used. The agarose 
plates were prepared by pouring 10 ml of molten agarose on to an 8 x 8 cm 
glass plate, giving 3 mm gel thickness. After cutting and clearing the 
wells, a drop of the antigen solution was loaded and electrophoresed at 
room temperature for about lh at lOV/cm.
After running, the agarose was cut 5 mm from the centre of the well. 
The strip containing the sample was retained whilst the rest was removed 
and discarded. For the second dimension, agarose containing antibodies 
was poured onto the remaining part of the plate and electrophoresed for 
about 18 h at 2 V/cm. After running, the non-precipitated proteins were 
removed by pressing the plates and washing out with 0.9% NaCl and with 
distilled water. The plates were then dried and stained for protein with 
Coomassie Brilliant Blue R-250 in 9:9:2 ethanol:water:glacial acetic
acid (Axelsen et aL, 1973) or with Sudan Black-B for lipid-containing 
lines (Clausen, 1969).
Polyacrylamide gel electrophoresis was performed in 8 cmx 5 mm glass 
tubes using a home-made electrophoresis apparatus. The stock solutions 
required were made as follows:
Acrylamide: 30 g acrylamide + 0.8 g bis-acrylamide dissolved and
diluted to a final volume of 100 ml with distilled water.
i
The solution was filtered if cloudy.
Tris pH 8.9: 36.3 of tris base + 48 ml NHC1 dissolved and made up to
100 ml with distilled water. (As with any buffer recipe, 
the correctness of the pH was verified.
Tris pH 6.7: 5.98 g of tris base dissolved in distilled water and
adjusted to pH 6.7 with HC1 and, finally, made up to 100 ml 
with distilled water.
10% SDS: 10 g of sodium dodecyl sulphate made up to 100 ml with
distilled water. SDS solutions precipitate in the cold, 
but redissolve immediately on warming.
TEMED: N,N,Nf jN'-tetramethylethylenediamine.
Persulphate: 10 g sodium persulphate per 100 ml.
Electrophoresis buffer (pH 8.9): 12 g tris base + 57.6g glycine made up to 21 
with distilled water. Add 101 SDS before use, 30ml/1 of buffer.
Membrane proteins were dissolved by heating for 3 min at 100°cin the 
following mixture:
1 ml tris pH 6.7 
0.9 ml glycerol 
0.01 ml mercaptoethanol
0.2 ml bromphenol blue (amount should be adequate to give a 
strong colour)
4.5 ml 101 SDS
Add water (2.4 ml) to make up to 9 ml.
Then the polacrylamide gels were prepared as follows:
5 ml acrylamide
1.88 buffer (tris-glycine) pH 8.9
0.15 ml 104 SDS
0.0075 ml TEMED
7.9 ml distilled water
0.075 ml freshly prepared ammonium persulphate
The tubes were filled with these solutions up to 7cm height and carefully 
overlaid with distilled water. When these gels were set, the water was 
removed and spacer gels were loaded, prepared from the same solutions as 
follows:
0.5 ml acrylamide
0.625 ml tris buffer pH 6.7
0.05 ml 104 SDS
0.0025 ml TEMED
3.77 ml distilled water
0.05 ml ammonium persulphate
These were then overlaid with distilled water as before. After 
polymerisation (about 20 min), samples were layered on top of the poly­
acrylamide. Electrophoresis was done for about 3h at room temperature 
in tris glycine buffer pH 8.3 (see above for details) using 5 mA/tube. 
Then the gels were stained for protein with Coomassie Brilliant Blue-G 
overnight which was prepared as below; then destained with several changes 
of distilled water till a clear background was obtained (Blakes ley and 
Boezi, 1977).
0.21 aqueous solution
Add equal volume of 2N H2S04
Stand for at least 3h
Filter through Whatman No.l
Add 1/9 volume (accurate) of ION KOH
Add 1001 w/v TCA to give final concentration of 12%
II-9 RAISING OF ANTI-(SERUM OF TUMOUR BEARING RATS) AND ANTI - (HEPATOMA 
PLASMA MEMBRANE) ANTIBODIES
Two rabbits were used to raise antibodies against serum of tumour 
bearing rats and hepatoma plasma membrane fragments. The plasma membrane 
used for immunisation was washed out with 0.15M-NaCl. This procedure 
should have removed traces of non-membrane protein which might adhere to 
the plasma membrane during the isolation procedure. Both antisera were 
raised by injecting the rabbits intramuscularly at two week intervals with
1.5 ml of the appropriate suspension. The suspensions were made up of 
0.5 ml of a 6 mg/ml solution of antigen protein in physiological 
phosphate-buffer saline (0.15M-NaCl/0.01M-phosphate, pH 7.5) (PBS) and 
1.0 mL of Freundfs complete adjuvant for the first injection. Incomplete 
adjuvant was used for the rest. Each rabbit received four injections.
After four weeks, another injection at the same protein concentration 
was given.
After 8 days, the rabbits were bled. The serum was separated and 
the globulin fraction was precipitated by adding, whilst stirring, an 
equal volume of saturated ammonium sulphate solution, and leaving the 
mixture overnight at 4°C, before collecting the precipitate by 
centrifugation. The precipitate was dissolved in 0.15M-NaCl to give 
a final volume of one-third that of the original serum. The solution 
was then dialysed against several changes of 0.15M-NaCl at 4°C for at 
least 24h. The diffusate was tested with barium chloride to ensure the 
complete removal of the sulphate.
III-l FRACTIONATION OF THE SERUM OF NORMAL AND TIMXJR-BEARING RATS
The sera of normal and tumour-bearing rats were fractionated by 
three different techniques: gel filtration, immunoelectrophoresis 
and polyacrylamide gel gradient electrophoresis.
(a) Gel filtration technique
(i) By using Sephadex G-200
The column of Sephadex G-200, prepared as discussed in 
Section II—7, was used to separate serum proteins on the basis of 
their molecular size. Large molecules, which cannot penetrate the 
pores of the bed molecules, pass through the column directly, while 
smaller molecules are retarded. The grade of Sephadex (G-200) used 
in this study can be used to fractionate globular proteins with 
molecular weights ranging between 5000-500000.
The distributions of the protein and various enzyme activities 
after gel exclusion chromatography of serum from (UA) tumour-bearing 
animals are illustrated on Fig. III-l, while those for normal serum 
(an experiment carried out by my colleague, Dr B. M. Mullock) are 
shown on Fig. III-2.
In the case of normal serum, all enzymes seem to run as a single, 
rather broad, band. Examination of the distribution of 5-nucelotidase 
after fractionating the serum of the (UA) tumour-bearing rats, shows 
a small peak in the early fractions, suggesting that a small quantity 
of this enzyme is associated with large molecules, which pass through 
in the void volume. The main peak of 5T-nucleotidase is found in 
fraction No. 26. The main peak of alkaline 3-glycerophosphatase
FIG. III-l Distribution of protein and various enzymes after 
fractionating the serumof a ’UA’ tumour-bearing rat 
on a 2.2 x 31.5 cm column of Sephadex G-200. The 
column was eluted by upward displacement with 0.15 M 
NaC£ and 3.5 ml fractions collected. The void 
volume of the column was 30 ml, corresponding to 
fraction No/9'
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FIG. III-2 Distribution of protein and various enzymes after 
fractionating the serum of normal rats on Sephadex 
G-200, as described in the legend to Fig. III-l.
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activity parallels that of 5’-nucleotidase. Peaks of alkaline 
p-nitrophenylphatase and alkaline phosphodiesterase activity were 
also found in the middle fractions of the run (§Fig. III-l).
(ii) By using Sepharose 4-B
Sepharose gels fractionate proteins on the same principle as 
Sephadex G-200, but are suitable for fractionating the large molecules 
which are excluded from Sephadex G-200. Whereas Sephadex provides 
excellent fractionation of globular proteins with molecular weights up 
to 500000, Sepharose 4-B may be used to separate molecules and 
particles up to molecular (particle) weights of several millions.
The sera of normal and of (UA) tumour-bearing rats were fractionated 
on such a column in an attempt to determine the molecular weight of 
the 5’-nucleotidase-carrying material which is excluded from 
Sephadex G-200. The distributions of proteins and various enzymes 
after gel filtration of noimal serum and the serum of tumour-bearing 
rats are illustrated in Fig. III-3 and Fig. III-4. The patterns of 
distribution of proteins for both types of serum seem to be similar. 
Examination of the distribution of 5'-nucleotidase showed a peak at 
fraction No. 44. Alkaline 3-glycerophosphatase showed a high 
activity at the same fraction. No peak corresponding to the material 
excluded from Sephadex G-200 could be detected and there were no 
significant differences from the pattern obtained with normal serum.
(b) Immunoelectrophoresis techniques
Serum proteins were analysed by crossed immunoelectrophoresis.
In the experiments described below, the serum was fractionated by 
agarose gel electrophoresis in the first dimension, followed by
FIG. III-3 Distribution of protein and various enzymes after 
fractionating the serum of normal rats on Sepharose 
4-B. The column was prepared and eluted in the same 
way as the column of Sephadex G-200 used in the 
experiment illustrated in Fig. III-l. Protein in:, 
fractions 36-39 is plotted at 1/100 of the scale 
used for other fractions.
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FIG. II1-4 Distribution of protein and various enzymes after
fractionating the serum of ’UA! tumour-bearing rats 
on Sepharose 4-B as described in the legend to 
Fig. II1-3, Protein in fractions 36-39 is plotted 
at 1 /1 0 0 of the scale used for other fractions.
fa) -------  protein
Qb) ▲----- A 5’-nucleotidase
□----- □ 3-glycerophosphatase

electrophoresis into an antibody-containing gel in the second 
dimension. The preparation of the agarose plates and the buffer used 
have been discussed in Section II-8.
(i) Serum proteins reacting with anti-(rat serum)
Sera of rats carrying (UA) and of rats carrying (WDA) hepatomas 
were examined. Fig. III-5 shows the patterns obtained with the sera 
of (UA) tumour-bearing and normal rats (the pattern for the serum of 
normal rats was obtained by my colleague Dr B. M. Mullock). The 
serum of (WDA) hepatoma-bearing rats gives a very similar pattern to 
that obtained with the serum of a normal rat. The serum of rats 
carrying the (UA) tumour did, however, show some differences. In 
normal serum the peak identified as HDL shows greater mobility in 
the first dimension than albumin. This peak could not be distinguished 
in the serum of rats carrying the (UA) hepatoma. There is also one 
peak apparent in the sera of rats carrying the (UA) tumour (marked by 
sign ’A’) which is not visible in the serum of normal rats. There 
are other differences between the two patterns, particularly at the 
region marked ’ □ which . are shown clearly in Fig. Ill-5.
To determine whether HDL was really absent from the serum of 
(UA) -carrying rats a lipoprotein fraction was obtained by flotation.
The sera of tumour-bearing and normal rats were mixed with 0.32 g/ml 
NaBr and spun for 18 h at 40000 revs/min. The floating fraction was 
collected and electrophoresed against anti-(rat serum). The plates 
were stained for lipid with Sudan Black-B. Fig. III- 6  shows the 
patterns obtained which indicate clearly that the HDL is present in 
the serum of the tumour-bearing rats.
FIG. III-5 Crossed immunoelectrophoresis of (a) normal rat serum,
(b) serum of ’UA.' tumour-bearing rat, (c) serum of 
’WDA’ tumour-bearing rat. Serum samples were diluted 1:10 
with 0.15 M NaCL. In the first dimension, an aliquot 
of about 7Ml of the diluted serum was electrophoresed 
for about 75 min at 10 v/cm in IV agarose containing 
0.44 M barb it one, pH 8 .6 . Electrophoresis in the 
second dimension was against a gel containing 41 anti- 
(rat serum). These plates are stained with Coomassie 
Brilliant Blue. The proteins marked are those 
described in the text.
+
+
FIG. III- 6  Crossed immunoelectrophoresis of
(a) lipoprotein of normal ftt serum
Cb) lipoprotein of the serum of fUA’ tumour-bearing rat
These lipoprotein fractions were obtained by flotation 
from whole serum adjusted to a density of 1 .2 2 g/ml by 
addition of 0.32 g/ml NaBr and spun for 18 h at 
40,000 rev/min. Electrophoresis of undiluted lipo­
protein against 4% anti-(rat serum) was carried out as 
described in Fig. III-5. These plates are stained with 
Sudan Black-B.
+
The slight differences between the patterns obtained after 
crossed immunoelectrophoresis of the serum of normal and tumour- 
bearing rats against anti-(rat serum) do not mean that there are no 
other differences between the proteins present in the sera of 
tumour-bearing rats and the serum of normal rats. As described 
below, I found a clear difference on crossed immunoelectrophoresis 
against anti-(hepatoma serum) and anti-(hepatoma plasma membrane) 
(Section III-3(c)).
(ii) Serum proteins reacting with anti-(plasma membrane)
Crossed immunoelectrophoresis of the sera of (UA) and (WDA) 
tumour-bearing rats and serum of normal rats against 101 anti- 
QLiver plasma membrane) gave the patterns illustrated in Fig. 111-7. 
Qualitatively, they seem identical but there are quantitative 
differences in the areas of peaks A and B. Table III-l shows the 
results of calculation of the area for each peak.
TABLE III-l Calculation of the areas of the two peaks A and B shown 
in Fig. Ill-7 (four separate experiments)
Experiment
No. Type of serum
Area of peak A Area of peak B 
in mm2 in mm2
1 Normal
WDA
UA
33.75
49.50
49.50
35.50
14.25
18.00
2 Normal
WDA
25.00
39.00
27.50
22.00
3 Normal
WDA
35.00
54.00
38.25
16.50
4 UA 20.25 8.00
FIG. IIT-7 Crossed immunoelectrophoresis of
(a) normal rat serum
(b) serum of ’UA’ tumour-bearing rat 68)
(c) serum of ’WDA’ tumour-bearing rat
-Vi;
The serum samples were diluted 1:4 with 0.15 M NaCL 
before electrophoresis. The first dimension was run 
as described in Fig. III-5. Electrophoresis in the 
second dimension was against a gel containing 101 
anti- (liver plasma membrane) . These plates were 
stained with Coomassie Brilliant Blue. The direction 
of electrophoresis in the first direction is marked 
with an arrow. fA ’ and TB’ are those which are 
described in the text.
ac
+

The results of four separate experiments are given. They show 
clearly that in the case of serum of normal rats, the area of peak A 
is less than that of peak B, but that this is reversed in the case 
of the sera of tumour-bearing rats.
(c) Polyacrylamide gel gradient electrophoresis technique
It is not possible to fractionate such a complicated mixture as 
the proteins of serum by any single fractionation method. Therefore 
it is very useful to study such a multicomponent system by 'two- 
dimensional’ separations, in which various components are spread out 
over a surface. The separation methods used in the two dimensions 
should exploit different properties of the material. As the 
separation of serum proteins in agar or agarose gel is dependent on 
the charges of the molecules, it can be usefully combined with 
equilibrium electrophoresis in polyacrylamide gel gradients in which 
the separation is principally dependent on particle size. In 
practice, a plate of 1% agarose was used, similar to that which was 
used for immunoelectrophoresis. Slots 16 mm long by 1 mm wide were 
cut about 2.5 cm from one edge of the plate. Then the sample which
had been diluted with an equal volume of 0.91 NaCit was loaded into
the slots. After.electrophoresis for about 90 min at 10 V/cm
the sample slots were filled with agarose and a slab 13 mm wide cut
out from each sample lane. This agarose strip was gently pushed 
edgewise into the loading space between the glass plates at the low 
density end of a polyacrylamide gradient gel, from which the 
preservative had been removed by preliminary electrophoresis for 
30-45 min at 40v in Tris-borate-EDTA buffer, pH 9.3 [10.12 g Tris + 
0.37 g boric acid + 0.96 gm Na2 EDTA/litre (Leaback, 1976)].
Electrophoresis in the second dimension was carried out for at 
least 15 h at 40V. The plates were stained for proteins with 0 .2% 
Coomassie Brilliant Blue R in 50% aqueous methanol to which 
7 ml/100 ml of glacial acetic acid were added immediately before 
use, and were destained electrophoretically.
Fig. III- 8  shows the results obtained for normal serum (results 
provided by Dr B . M. Mullock) and the serum of (UA) tumour-bearing 
rats. The serum of tumour-bearing rats contains distinct proteins 
not found in the serum of normal animals. Major proteins appear 
similar in both cases. However, the protein marked (1) in 
Fig. III-8b, which was also detected in the serum of jaundiced rats 
(Hinton and Mullock, 1977), is almost certainly the injury macro­
globulin (Gordon, 1976) which is essentially absent from the serum 
of noimal rats. Region (2), which contains the 8-lipoproteins, shows 
a quite different appearance in the tumour serum plate from that of 
normal serum. There are also some bands in the pattern of normal 
serum which are not visible in the serum of tumour-bearing rats 
(marked as region (3)).
Serum glycoproteins in polyacrylamide gel gradients
Undiluted serum was used, but otherwise the procedure for two 
dimensional electrophoresis was as described in the previous 
paragraph. Finally, the plates were stained for glycoproteins using 
periodic acid and Schiff’s reagent. Fig. III-9 shows the results 
for the serum of (UA) and (WDA) tumour-bearing rats. The pattern for 
normal serum obtained by Dr B. M. Mullock is included for comparison. 
The patterns seem similar and the major proteins contain carbohydrate 
groups. However, the result obtained for (WDA) tumour-bearing rats
FIG. III- 8  Two dimensional electrophoresis of the serum of normal 
and ’UA’ tumour-bearing rat. The first dimension was 
run in 1% agarose in 0.44 M barbitone buffer, pH 8 .6 . 
The second dimension was run in a Gradipore 3-26% 
polyacrylamide gradient gel in tris-borate-EDTA buffer, 
pH 9.3. A detailed account of the procecure is given 
in the text. The samples were diluted 1+1 with 0.15 M 
NaC£, The direction of electrophoresis in the first 
dimension is marked in each figure.
(a) normal rat serum
(b) serum of 'UA1 tumour-bearing rat
The proteins marked are those described in the text.

FIG. III-9 Pattern of glycoproteins in
(a) normal rat serum
(b) serum of TUA! tumour-bearing rat
(c) serum of ’WDAT tumour-bearing rat
Two-dimensional electrophoresis was carried out as 
described in Fig. III-8 , except that the serum was not 
diluted prior to use. These plates were stained for 
glycoprotein using periodic acid and Schiff’s reagent. 
The direction of electrophoresis in the first 
dimension is marked on each figure.


shows slight differences from that of normal serum at the region 
(marked (4)) in Fig. III-9c. Since the protein in this region 
moves more slowly than albumin, the protein may be a-foetoprotein 
(AFP), which has a molecular weight 75100 higher than albumin 
(Lowing, 1977). Alternatively, it could be a specific protein in 
the serum of tumour-bearing rats as described below (Section III-3c).
Ill—2 ISOLATION OF PLASMA MEMBRANE FROM NORMAL LIVER AND HEPATOMA
(a) Electron microscope studies of the plasma membrane of
hepatoma cells
Sections from two different hepatomas were examined by electron 
microscopy (using a JEM electron microscope). The procedure for 
preparing these sections was described in Chapter II-6. Fig. 111-10 
shows a section taken from the slow growing 'WDAT tumour-carrying rat. 
Hie figure shows clearly the cell plasma membrane (marked PM). When 
following the plasma membrane around the cells one finds a region 
whose structure, between cells, resembles that of the bile canaliculus 
in liver cells. This is shown in more detail in Fig. Ill-ll(a). 
Furthermore, in other regions of the tumour cell, the appearance of 
the plasma membrane resembles the sinusoidal face region of the liver 
cell CFig. IH-ll(b)).
The appearance of cells from the fast-growing ’HA’ hepatoma 
(Fig. II1-12) was rather different. This figure shows that the plasma 
membrane of the ’UAT tumour has less structural organisation than that 
of the ’WDA' tumour. However, junctional complexes between adjacent 
cells are seen in Fig. 111-13. On further examination of this and
FIG. III-10 Electron micrograph of a section from the 'WDA’
hepatoma. The section was fixed with 11 glutaraldehyde 
and in 2% osmic acid. After embedding, the section was 
counterstained with alkaline lead citrate and uranyl 
acetate. The regions marked by the arrows are shown in 
the next figure at higher magnification.
Magnification x 8640

FIG. 111-11 (a) A detail of the section shown in Fig. III-10
which shows a region whose structure, between 
cells, resembles that of the bile canaliculus 
in liver cells.
Magnification x 20,000
Qb) A details of the section shown in Fig. 111-10 
which shows a region whose structure resembles 
the sinusoidal face region of the liver cell.
Magnficiation x 22,000

FIG. TII-12 Electron micrograph of a section from the ’UAl
hepatoma. The section was treated as described in 
Fig. 111-10, The region marked by the arrow is 
shown in the next figure at higher magnification.
Magnification x 7100

FIG. III-13 A detail of the section shown in Fig. 111-12. This 
region shows a junctional complex between adjacent 
cells.
Magnification x 12,800
■ .,r: .
many other sections we could not find a structure resembling that of 
bile canaliculi as in liver cells.
(b) Isolation of large sheet fragments of plasma membrane
Ci) Normal liver
As mentioned in the Introduction, many investigators have shown 
that, after homogenisation of liver, the plasma membrane breaks into 
large sheets which sediment with nuclear fraction, and small vesicles 
recovered in the microsomal fraction. -Methods for the purification of 
plasma membrane sheets from nuclear fraction have been reported from 
this laboratory (Hinton et al., 1970); Issa, 1976). Since the red 
blood cells aggregate with the plasma membrane fragments, the liver 
was perfused with 0.25 M sucrose to remove the red blood cells.
However, in my study the liver was not perfused but the plasm membrane 
fragments, were separated from the red blood cells by flotation. In 
brief, the livers were homogenised in 0.25 M sucrose containing 5 mM 
tris-HC£ pH 8 . After filtration through a coarse sieve, the density 
of the homogenate was adjusted to density 1.18 g/ml (ref. index - 1.40) 
and after overlaying with 0.25 M sucrose, spun in an (8 x 50) ml angle- 
head rotor for 30 min at 12000 revs/min. The interface layer was 
removed with a bent pipette and diluted four times with 0.25 M sucrose 
then spun again and a sample was taken as a reference. The pellet 
was washed twice by resuspension in 0.25 M sucrose and pelleting using 
a M.S.E. Minor bench centrifuge. Each centrifugation was for 15 min, 
the first being at setting No. 8 and the second at setting No. 5.
Finally, the pellet was suspended in30mlof0.25M sucrose. The enzymes 
assayed.were: 5’-nucleotidase, glucose-6-phosphatase, acid phosphatase and 
succinate dehydrogenase, which were respectively used as markers for
plasma membrane, endoplasmic reticulum, lysosomes and mitochondria.
Table III-2 shows the results of purification and yield of these 
various marker enzymes.
The results showed that a reasonable purification of plasma 
membrane fragments as indicated by 5-nucleotidase, was achieved by 
the procedure described above. But this plasma membrane fraction 
still contained as contaminants significant amounts of endoplasmic 
reticulum, mitochondria and a very low amount of lysosomes as 
judged by their marker enzymes, glucose-6-phosphatase, succinate 
dehydrogenase and acid phosphatase respectively. The comparison of 
these results with those obtained by Issa (1976) is discussed in 
Chapter IV.
(ii) Hepatoma
A method for the isolation and purification of plasma membrane 
from a slow-growing hepatoma was developed in this laboratory by 
Prospero (1975) who used centrifugal techniques employing exponential 
gradients (details of the gradient are described in Section II-5(a)). As 
mentioned in Chapter II, Materials and Methods, two sublines of 
tumour were used in the present study, the first of which is fast 
growing with a generation time between 2-3 weeks (’UA* tumour) and 
the second is slower growing with a generation time of about 6 weeks 
(jWDA1 tumour). Attempts were made to separate plasma membrane 
fragments from both, using the techniques of Prospero (1975). The 
floated fraction, obtained from the whole hepatoma homogenate after 
adjusting to a density of 1.18 g /ml and centifruging for 50 min at
133,000 xg, was loaded into the HS zonal rotor and centrifuged for 
18 min at 9,000 revs/min. Figs. 111-14 and 111-15 show the
TABLE III-2 Purification and yield of various marker enzymes during 
preparation of plasma membrane fraction by centrifugation 
the whole liver homogenate for 30 min at 12,000 rev/min 
in 8 x 50 ml rotor. (The results of two separate 
experiments are given.)
Specific activity
y moles/ % Yield 
mg protein/min
Purification
5-Nucleotidase
Homogenate 0.069 ; 0.053 100 1
Fraction floating at 
density = 1.18
0.127 ; 0.076 37.59 ; 29.44 1.82 ; 1.41
Fraction after 
pelleting and washing
0.902 ; 0.674. 26.1 .; 12.58 13 • ; 12.57
Glucose-6-phosphatase
Homogenate 0.082 ; 0.053 100 1
Fraction floating at 
density =1.18
0.045 ; 0.042 11.409 ; 16.38 0.55 ; 0.79
Fraction after 
pelleting and washing
0.026 ; o 0.648 ; 0 0.32 ; o
Acid phosphatase
Homogenate 0.049 ; 0.046 100 1
Fraction floating at 
density =1.18
0.045 ; 0.031 18.89 ; 13.76 0.919 0.67
Fraction after 
pelleting and washing
0.008 ; o 0.33 ; o 0.164 9 0
Succinate dehydrogenase
Homogenate 0.047 .; 0.034 , 100 1
Fraction floating at 
density = 1.18
0.016 ; 0.032 7.16 ; 19.53 0.347 9 0.947
Fraction after 
pelleting and washing
0.027 ; 0.0058 0.59 ; 0.26 0.589 9 0.17
FIG. 111-14 Distribution of protein and marker enzymes after 
centrifugation of a fraction isolated from a ’UA' 
hepatoma homogenate by flotation at density 1.18. 
Centrifugation was for 18 min at 9000 revs/min in 
the HS zonal rotor.
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FIG. 111-15 Distribution of protein and marker enzymes after.
centrifugation of a fraction isolated from a ’WDA1 
hepatoma homogenate by flotation at density 1.18. 
Centrifugation was for 18 min at 9000 revs/min 
in the HS zonal rotor.
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distribution of protein and various marker enzymes after fractionating 
material floated from homogenates of the TUA' and fWDA' tumours.
The early part of the gradient (fractions 3-7) contains soluble 
proteins and small particulate components which have not sedimented 
away from the sample region. However, a clear zone of plasma 
membrane fragments, indicated by 5-nucleotidase activity is found at 
a density of between 1.12-1.15 g/ml. Analysis of marker enzymes 
showed that the plasma membrane zone in the central part of the 
gradient is only slightly contaminated hy endoplasmic reticulum 
fragments and lysosomes. There was a significant contamination by 
mitochondria in the case of preparing large sheets of plasma membrane 
from the ’UA.’ tumour while there were virtually no mitochondria in 
preparing large sheets of plasma membrane from 'WDA’ tumour, as judged 
by the lack of succinate dehydrogenase activity.
Tables II1-3 and III-4 show the purification and yield of various 
marker enzymes for both tumours. The Figures and Tables also show 
the distribution of other enzymes such as alkaline phosphodiesterase and 
alkaline 3-glycerophosphatase, which appear to be almost entirely 
localised in the plasma membrane fragments.
(c) Separation of plasma membrane vesicles
The microsomal fraction was obtained by centrifuging at 
40,OCX) revs/min for 1 h the supernatant obtained from the hepatoma 
homogenate centrifugation at 10,000 revs/min for 15 min. The pellet 
of microsomes was suspended in 2 M sucrose containing as a buffer 
5 ihM tris-HCJl pH 8 . After a sample had been taken out as a reference, 
the rest of the fraction (22 ml) was injected into the edge of the
TABLE III-3 Purification and yield of various marker enzymes during
preparation of plasma membrane fraction by centrifugation 
of the floated material from the whole (UA) hepatoma 
homogenate for 18 min at 9,000 rev/min in HS zonal rotor. 
The results are given as means ± standard error. Unless 
otherwise indicated the results are averaged from two 
experiments.
Specific activity
]i moles/ % Yield Purification 
mg protein/min
5-Nucleotidase (3)
Homogenate 0.186 + 0.0103 100 1
Floated material 
loaded into the 
zonal rotor
1.33 ± 0.121 9.6 ± 0.625 6.77
Zonal plasma-membrane 1.77 +0.588 1.32 ± 0.632 9.95 .
Glucose-6-phosphatase (3)
Homogenate 0.0067 ± 0.0023 100 1
Floated material 
loaded into the 
zonal rotor
0.0167 ± 0.0032 3.305 ± 1.635 2.27
Zonal plasma-membrane 0.01 ± 0.005 0.376 ± 0.162 1.36
Acid phosphatase (3)
Homogenate 0.025 ± 0.0006 100 1
Floated material 
loaded into the 
zonal rotor
0.078 ± 0.012 3.032 ± 1.536 3.03
Zonal plasma-membrane 0.033 ± 0.016 0.268 ± 0.146 1.29
Succinate dehydrogenase
Homogenate 0.0108 100 1
Floated material 
loaded into the 
zonal rotor
0.0048 0.84 0.584
Zonal plasma-membrane 0.0132 0.27 1.443
Cont.
TABLE III-3 (Cont)
Alkaline 3-glycerophosphatase (3)
Homogenate 0.0088 ± 0.0008 100 1
Floated material 
loaded into the 
zonal rotor
0.053 ± 0.013 7.43 ± 2.211 6.04
Zonal plasma-membrane 0.04 ± 0.0098 0.74 ±0.086 4.65
Specific activity
U W /  .
mg protein/min
% Yield Purification
'*••'•.11
Alkaline phosphodiesterase (3)
Homogenate 2.04: ± 0.336 100 1
Floated material 
loaded into the 
zonal rotor
12.04. ± 1.87 9.40: ± 0.59 10.33
Zonal plasma-membrane 22.92 ± 9.67 1.74 ± 0.368 10.67
Alkaline 'p-nitrophenylphosphatase (3)
Homogenate 2.41. ± 0.223 100 1
Floated material 
loaded into the 
zonal rotor
14.81 ± 1.108 9.55 ±0.59 6.47
Zonal plasma-membrane 27.44 ± 13.45 1.75 ±0.527 10.89
TABLE 111-4 Purification and yield of various marker enzymes during
preparation of plasma membrane fraction by centrifugation 
of the floated material from the whole (WDA) hepatoma 
homogenate for 18 min at 9,OCX) revs/min in HS zonal rotor. 
(The results are given for one experiment only.)
Specific activity 
y moles/ 
mg protein/min
% Yield Purification
5-Nucleotidase
Homogenate
Floated material 
loaded into the 
zonal rotor
Zonal
plasma-membrane
0.053
0.609
0.576
100
12.43
4.25
1
11.49
1 0 .8 6
G lucose-6-phosphatase
Homogenate 0.006 100 1
Floated material 
loaded into the 
zonal rotor
0 .0 2 3.4 3.33
Zonal
plasma-membrane
0.014 0.9 2.46
Acid phosphatase
Homogenate 0.024 100 1
Floated material 
loaded into the 
zonal rotor
0.097 4.27 3.89-
Zonal
plasma-membrane
0.091 1.44 3.65
Alkaline 3-glycerophosphatase
Homogenate 0.015 100 1
Floated material 
loaded into the 
zonal rotor
0.316 22.71 21.06
Zonal
plasma-membrane
0.389 1 0 .1 1 25.93
Cont.
TABLE III-4 (Cont)
Specific activity
M?/ .
mg protein/min
4 Yield Purification
Alkaline p-nitrophenylphosphatase
Homogenate 5.92 .1 0 0 1
Floated material 
loaded into the 
zonal rotor
78.31 0.14 13.22
Zonal plasma-membrane 108.42 7.22 18.31
Alkaline phosphodiesterase
Homogenate 2.32 100 1
Floated material 
loaded into the 
zonal rotor
25.28 11.85 10.89
Zonal
plasma-membrane
32.28 5.48 13.91
B-XIV zonal rotor, under the linear gradient. The rotor was then 
filled completely with 2 M sucrose as a cushion and was accelerated 
to 44,000 revs/min. After centrifugation for about 16 h the rotor 
was decelerated to the loading speed and the contents displaced. The 
distribution of marker enzymes and protein after fractionation of
a
microsomes from tumours 'HA* and ’WDA’ are shown in Figs. 111-16 and 
111-17. The first sharp peak at density range between 1.11-1.14 
represents the plasma membrane fragments as judged by the 
5-nucleotidase pattern. The bulk of the activity of glucose-6- 
phosphatase is found at the second peak, which indicates that the 
endoplasmic reticulum fragments are located at the density range 
1.17-1.20. The lysosomal marker acid phosphatase shows a pattern 
similar to the 5!-nucleotidase and therefore indicates that the plasma 
membrane region is contaminated with lysosome fragments.
From the distribution of marker enzymes one can conclude that a 
reasonably pure sample of a plasma membrane fragment can be obtained 
by pooling fractions (4-9). These fractions are only slightly 
contaminated by other subcellular organelles such as endoplasmic 
reticulum, lysosomes and mitochondria (Figs. 111-16 and III—17]).
The plasma membrane fragments used to raise the anti- (tumour plasma 
membrane) antiserum were prepared in this way. The pooled; fractions 
were diluted with an equal volume of distilled water and the vesicles 
collected by centrifugation for 90 min at 40,000 revs/min. The 
pellet was then washed twice by resuspension in 0.15 M NaC£ and 
recentrifuged for 90 min at 40,000 revs/min.
The purifications and yields of various marker enzymes are shown 
in Tables III-5 and III-6  for both tumours. It must also be mentioned
FIG. 111-16 Distribution of protein and marker enzymes after
flotation for 16 h at 44,000 revs/min in a B-XIV zonal 
rotor of the microsomal fraction separated from a ’UA.’ 
hepatoma homogenate by centrifugation for 60 min at
40,000 revs/min of the supernatant remaining after 
large particles had been removed by centrifugation 
for 15 min at 10,000 revs/min.
The microsomal fraction was resuspended in 25 ml of 
2M-sucrose and introduced at the dense end of a linear 
sucrose density gradient ranging from a density of 
1,077 to a density of 1.22 g/ml.
(a) density
O— — O 5’-nucleotidase
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+----- + AT-pase
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▼— --- ▼ alkaline phosphodiesterase
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FIG. III-17 Distribution of protein and marker enzymes after 
flotation for 16 h at 44,000 revs/min of the 
microsomal fraction of a ’WDA’ hepatoma homogenate. 
Experimental conditions were the same as in the 
experiment illustrated in Fig. 111-16.
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TABLE III—5 Purification and yield of various marker enzymes during
preparation of plasma membrane fraction by centrifugation 
of microsomal fraction of (UA) hepatoma for 16 h at
44,000 revs/min in B-XIV zonal rotor. The results are 
given as means ± standard error. Unless otherwise 
indicated the results are averaged from two experiments.
Specific activity 
y moles/ 
mg protein/min
% Yield Purification
5-Nucleotidase (6)
Homogenate 0.191 + 0.0155 100 1
Material loaded 
into the zonal 
rotor
0.338. + 0.0099 -,18.47 ± 0.465 1.78
Zonal
plasma-membrane
2.128 ± 0.365 8.84 ± 1.45 1 1 .1 0
Glucose-6-phosphatase (6)
Homogenate 0.0062 ± 0.0004 100 1
Material loaded 
into the zonal 
rotor
0.0094 ± 0 .0 0 1 15.47 ±1.77 1.52
Zonal
pi asma-membr ane
0.455 ± 0.0007 1.824 ± 0.571 2 .1 0
Acid phosphatase C6)
Homogenate 0.028 + 0.0023 100 1
Material loaded 
into the zonal 
rotor
0.053 . ± 0.0035 19.32 ± 0.861 1 .8 6
Zonal
pi asma-membr ane
0.171 ± 0.0412 4.74 ± 1.072 5.84
Alkaline B-glycerophosphatase (6)
Homogenate 0.0082 ± 0 .0 0 1 100 1
Material loaded 
into the zonal 
rotor
0.104 ± 0 .0 0 1 13.2 ± 0.47 1.28/
Zonal
plasma-membrane
0.0508 + 0.0095 4.88 ±0.89 6.25
TABLE III-5 (Cont)
Succinate dehydrogenase
Homogenate 0.0136 100 1
Material loaded 
into the zonal 
rotor
0.0052 4.05 0.376
Zonal
plasma-membrane
0.0044 0.461 0.386
Adenosine triphosphatase
Homogenate 0.105 100 1
Material loaded 
into the zonal 
rotor
0.136 22.5 1.29
Zonal
plasma-membrane
0.693 4.06 6.53
Specific activity
y g / % Yield Purification
mg protein/min
Alkaline p-nitrophenylphosphatase (6)
Homogenate 1.72 + 0.643 100 1
Material loaded 
into the zonal 
rotor
3.58 + 1 .2 1. 25.16 ± 5.02 2.48
Zonal
plasma-membrane
23.09 + 11.81 11.7 ±4.40 ,14.27
Alkaline phosphodiesterase (6)
Homogenate 1.44 + 0.182 . 100 1
Material loaded 
into the zonal 
rotor
3.32 + 0.292 24.30 ± 2.45 2.36
Zonal
plasma-membrane
17.14 + 4.225 9.06 ± 0.917 12.06.
TABLE III-6 Purification and yield of various marker enzymes during 
preparation of plasma membrane by centrifugation of 
microsomal fraction of (WDA) hepatome for 16 h at
44,000 revs/min in B-XIV zonal rotor. (The results 
given are for two experiments.)
Specific activity 
y mole/ 
mg protein/min
% Yield Purification
5-Nucleotidase
Homogenate 0.081 100 1
Material loaded 
into the zonal 
rotor
0.24 19.30 2.98
Zonal
plasma-membrane
0.846 13.02 10.62
Glucose-6-phosphatase
Homogenate 0.0073 100 1
Material loaded 
into the zonal 
rotor
0.0115 9.90 1.51
Zonal
plasma-membrane
0.024 4.25 3.24
Acid phosphatase
Homogenate 0.032 100 1
Material loaded 
into the zonal 
rotor
0.115 23.98 3.93
Zonal
plasma-membrane
0.149 5.80 4.85
Alkaline B-glycerophosphatase
Homogenate 0.043. 100 1
Material loaded 
into the zonal 
rotor
0.181 25.62 4.09
Zonal
plasma-membrane
0.484 12.75 10.88
Cont.
TABLE III-6 (Cont)
Specific activity
y g I
mg protein/min
% Yield Purification
Alkaline jS>-nitrophenylphosphatase
Homogenate 10.43 100 1
Material loaded : 
into the zonal 
rotor
43.72 26.09 4.09
Zonal
plasma-membrane
116.64 14.01 11.03
Alkaline phosphodiesterase
Homogenate 2.61 100 1
Material loaded 
into the zonal 
rotor
11.69 28.24 4.44
Zonal
plasma-membrane
26.93 12.46 10.24
that this region shows activities for other plasma membrane enzymes 
such as ATPase, alkaline phosphatase assayed with ^ -nitrophenyl 
phosphate as substrate, and alkaline phosphodiesterase. This 
observation means that those enzymes exist in the same site of plasma 
membrane fragments. The comparison between two sets of results for 
’UA.’ and ’WDA1 tumours, obtained by using the above procedure, is 
discussed in the next chapter.
Cd) Fractionation of membrane proteins on polyacrylamide gels
Fractions from an experiment similar to that illustrated in 
Fig. 111-16 were pooled in groups of four. The pooled fractions 
were diluted with water and particulate material collected by 
centrifugation and washed by resuspension with 0.15 M NaC£. Samples 
from these suspensions were treated with SDS and mercaptoethanol as 
described in Section 11-8, and fractionated on polyacrylamide gels.
The method for preparing the gels and the buffers which were used 
has been described above . The patterns obtained are shown in 
Fig. III-18. The first fractions, Fig. Ill-18(a) (fractions 1-4) 
contain contain very little protein while the others contain quite a 
lot of material as shown by the patterns of the bands. The bands 
numbered 1 to 5 are found in all fractions. Comparison with the 
distribution of enzymes (Fig* HI-16) suggests that these proteins 
are associated with the endoplasmic reticulum. However, Fig. III-18(b) 
which represents the fractions rich in plasma membrane fragments, also 
shows additional bands, presumably due to plasma membrane components. 
These results give further evidence that the plasma membrane fragments 
are contaminated by other organelles such as endoplasmic reticulum.
FIG. III-18 Polyacrylamide-gel electrophoresis in 0.05 M tris - 
0.4 M glycine buffer, pH 8.3 of the proteins of 
microsomal subfractions separated from the microsomal 
fraction of a 'UA' hepatoma homogenate as illustrated 
in Fig. Ill-16.
The pooled fractions were diluted with distilled 
water and particulate material collected by centri­
fugation for 90 min at 40,000 rev/min and washed by 
resuspension with 0.15 M NaCJl and repelleting.
Electrophoresis was performed for 3 h at room 
temperature using 5 mA/tubes. The gels are stained 
with Coomassie Brilliant Blue-G. The bands marked 
1 to 5 are those discussed in the text.
(a) Pool of fractions 1 to 4
(b) Pool of fractions 5 to 9
(c) Pool of fractions 10 to 13
(d) Pool of fractions 27 to 30
Ill II
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Ill—3 COMPARISON OF PROTEINS IN THE SERUM OF NORMAL AND
TUMDUR-BEARING RATS
(a) Proteins reacting with antisera prepared against the serum 
of normal and *UA! tumour-bearing rats
Crossed immunoelectropheresis of serum from both 'UA and ’WDA’ 
tumour-bearing rats against an antiserum prepared against the serum 
of ’UA1 tumour-bearing rats (anti ’UA’ serum) gave a complex pattern 
(Fig. III-19(a) and III-19(b)). The patterns seem identical, at 
least as regards the main proteins. However, by using an intermediate 
gel technique it was possible to demonstrate that the serum of 'UA' 
and 'WDA’ tumour-bearing rats each show a specific protein 
(Fig. Ill—20(jb) and Fig. III-20(c)), neither of which is present in 
the serum of noimal rats (Fig. III-20(a)). The two tumour specific 
proteins differ in their mobility in the first dimension. In the 
case of the serum of ’UA’ tumour-bearing rats, this specific protein 
moves more slowly than albumin, while its counterpart in the serum 
of ’WDA' migrates as a prealbumin. The serum of rats carrying the 
’UA’ hepatoma was also tested against an antiserum prepared against 
the serum of laparotomised animals (Fig. III-20(d)). Experiments by 
other workers in this laboratory had shown that this antiserum 
contains antibodies reacting with some ’injury’ proteins. However, 
the pattern obtained with the serum of tumour-bearing rats is 
indistinguishable from that obtained using normal serum 
(§Fig. III-20(a)),
(b) Proteins reacting with anti-(liver plasma membrane) and 
anti-( ’UA* hepatoma plasma membrane
Sera from ’UA’ and ’WDA’ tumour-bearing rats and normal serum
FIG. 111-19 Crossed imrnunoelectrophoresis of
(a) serum of ’UA’ tumour-bearing rat
(b) serum of ’WDA’ tumour-bearing rat
The first dimension was run as described in Fig. II1-5. 
Electrophoresis in the second dimension was against a 
gel containing 51 anti-(serum of ’UA’ tumour-bearing 
rat). The plates are stained with Coomassie Brilliant 
Blue,
/ '
b
+
FIG. 111-20 Crossed immunoelectrophoresis o£
(a) normal rat serum
(b) and (d) serum of ’UA’ tumour-bearing rat
(c) serum of ’WDA’ tumour-bearing rat
The first dimension was run as described in Fig. III-5.
The second dimension was run for 18 h at 2 V/cm against
a split antibody-containing gel made up as follows:
(a) 9 0>) and Cc) 101 anti- (rat serum) in the lower part 
and 101 anti-(serum of ’UA' tumour-bearing rat) in 
the upper part.
Cd) 101 anti-(rat serum) in the lower part and 101
anti-(serum of laparotomised rat) in the upper part..
The plates were stained with Coomassie Brilliant Blue.
The proteins marked are those described in the text.


were examined by crossed immunoelectrophoresis against anti-C’UA.' 
heptaoma plasma membrane) prepared as described in Section 11-9 
(Figs.Ill-21(a-c)). The antiserum reacted strongly with a number of 
major serum proteins. Three proteins showed interesting changes 
between normal serum and the serum of tumour-bearing rats. These 
are marked (A), (B) and (C) in the figures.. Protein (A) 
appears as a double peak in all sera, but the proportion of the 
more rapidly moving component is greater in the serum of tumour- 
bearing rats. Examination of the patterns shows a specific protein, 
(B), is present in the sera of tumour-Bearing rats but not in normal 
serum (Figs.III-21 (b), (c)). Finally an extra protein, (C), is 
present in the sera of rats carrying the ’UA’ hepatoma but absent 
from the serum of rats carrying the ’WDA’ tumour and normal serum. 
Further experiments showed that protein (B) has antigenic 
determinants in common with some protein of normal serum 
(Figs.III-22(a), (b)), but that protein (C) is immunologically 
unrelated to normal serum protein.
Figs. 111-23 (a), (b) show the patterns obtained of the serum 
of !UA’ and ’WDA’ tumour-bearing rats after crossed iramunoelectro- 
horesis against a split antibody gel containing 10% anti-(liver 
plasma membrane) in the lower gel, and 101 anti-C’UA’ hepatoma 
plasma membmae) in the upper gel. These figures show that neither 
proteins (B) nor (C) react with anti- (liver plasma membrane).
FIG. 111-21 Crossed immunoelectrophoresis of
(a) normal rat serum 'v:t!
(b) serum of ’UA’ tumour-bearing rat
(c) serum of ’WDA* tumour-bearing rat.
The first dimension was run as described in Fig. III-5.
(a) Electrophoresis in the second dimension was against 
a split antibody-containing gel as 10% anti-('UA’ 
hepatoma plasma membrane) in the lower part and 10 
anti-(rat serum) in the upper part.
(b) and (c) Electrophoresis in the second dimension was 
against a gel containing 10% anti-(’UA’ hepatoma 
plasma membrane).
The plates are stained with Coomassie Brilliant Blue.
’A ’, ’B’ and ’C' indicate the three proteins which are
discussed in the text.
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FIG, 111-22 Crossed iraraunoelectrophoresis of
Ca) normal rat serum
(b) serum of ’UA’ tumour-bearing rat
The first dimension was run as described in Fig. III-5. 
Electrophoresis in the second dimension was against a 
split antibody-containing gel with 101 anti-(rat serum) 
in the lower part and 101 anti-C’UA' hepatoma plasma 
membrane) in the upper part. The plates are stained 
with Coomassie Brilliant Blue.
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FIG. 111-23 Crossed immunoelectrophoresis of
(a) serum of ’UAl tumour-bearing rat
(b) serum of ’TCDA* tumour-bearing rat
The first dimension was run as described in Fig. III-5. 
Electrophoresis in the second dimension was against a 
split antibody-containing gel as 101 anti-(liver plasma 
membrane) in the lower part and 101 anti-( ’UA' hepatoma 
plasma membrane) in the upper part. The plates are 
stained with Coomassie Brilliant Blue.
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III-4 STUDIES ON PHOSPHATASES
(a) Studies on 5-nucleotidase in serum and the plasma membrane
of noimal liver and hepatoma
(i) Comparison of the properties of liver plasma membrane 
and 5-nucleotidase
The pH-dependence of 5-nucleotidase in serum and plasma membrane 
fragments was examined using a variety of buffers. Figs. III-24(a) ,(b) 
show the patterns which were obtained. Fig. III-24(a) shows that the 
pH optimum of plasma membrane 5-nucleotidase depends on the buffer 
employed. With tris buffer the pH optimum of plasma membrane 
5-nucleotidase was between 7.3-7.5. Higher activities were obtained 
with glycine and glycylglycine buffer and in these buffers the pH 
optimum was around 9.0. The results obtained with bicarbonate buffer 
were consistent with a similar pH optimum but the absolute activities 
were much lower than those obtained with glycine or glycylglycine at 
the same pH.
Similar studies were carried out on the 5-nucleotidase in normal 
rat serum. Five different buffers were employed. The enzyme activity 
in normal serum showed a much more marked dependence upon the pH than 
the enzyme in liver plasma membrane. A change of 0.5 pH units 
produces a several-fold increase in activity. Fig. III-24(b) shows 
the pH curves obtained with each buffer. Dimethylg-lutarate appeared 
to inhibit the enzyme. With tris buffer the optimum pH was around
8.5. Bicarbonate and glycylglycine gave almost the same activity as 
tris but at a pH optimum of 9.0. Glycine appeared to inhibit the 
enzyme but the results are consistent with an optimum pH of around
8.5.
FIG. 111-24 Activity of 5’-nucleotidase in .
(a) liver plasma membrane fragments 
(jb) noimal rat serum
as a function of pH. The buffers employed were as
follows:
v---v tris
A— :— ▲ glycine
o— o bicarbonate
■-— ■ glycylglycine
•— « dimethylglutarate
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(ii) The relationship between hepatoma and liver 5-nucleotidase
Hepatoma plasma membranes are rich in 5-nucleotidase. The 
relationship of this enzyme to the 5-nucleotidase of liver plasma 
membrane has been examined by using the Ouchterlony double diffusion 
technique. In brief, a sample of hepatoma plasma membrane fragments 
was extracted by treatment with an equal volume of a detergent 
mixture (0.51 Lubrol and 1% deoxycholate) for about 2 h at 0°C. The 
mixture was centrifuged at 50,000 revs/min for \ h to remove 
•insoliibilised proteins. Plates of 1.51 agar in 0.3 M phosphate buffer 
pH 7.4 were prepared and the wells cut using a home-made cutter. The 
sample at three different concentrations was loaded into some of the 
wells while others were filled with anti-liver plasma membrane, 
anti-cytosol and anti-liver microsomes as shown in Fig. 111-25. The 
plates were left for two days. Unprecipitated proteins were removed 
by washing with several changes of 251 saline for two days. The 
plates were then washed with distilled water to remove salt. One of 
the plates was incubated at 37°C for about 2 h with 30 ml of a 
staining mixture (50 mM DMG pH 7.5, 2 mM Pb(N03)2, 5 mM Mg(N03)2 
and 50mM UMP) while the other plate, used as a blank, was incubated 
for the same period of time with the same mixture but without 50mM 
UMP. The plates were rinsed with distilled water and then immersed 
in a 0.21 solution of yellow amminium sulphide for a few minutes.
Fig. II1-25 shows the pattern obtained. There are clear lines 
between the wells which contain the samples of hepatoma plasma 
membrane and those containing anti-liver plasma membrane or anti­
liver microsomes. This indicates that the 5-nucleotidase of hepatoma 
plasma membrane is identical to that of liver plasma membrane.
FIG. 111-25 Reaction of 51-nucleotidase in extracts of !UAT 
hepatoma homogenate membranes with a variety of 
antisera. The sample was extracted by treatment with 
an equal volume of a detergent mixture (0.51 lubrol 
and 1% deoxycholate) for about 2 h at 0°C, and 
centrifugation for 30 min at 50,000 revs/min to 
remove insolubilised proteins. Three different 
concentrations of the sample were used against anti- 
(liver plasma membrane), anti-(liver cytosol) and 
anti- (liver microsomes). The diffusion and 
precipitation were allowed to proceed for 48 h at 
room temperature. The unprecipitated proteins were 
washed off by soaking in 2.5% NaC£ for 2 days 
followed by distilled water. The plates are stained 
for 5’-nucleotidase as described in the text.
(a) The incubation mixture contained (50 mM UMP)
(b) The plate contained no UMP

(b) Non-specific alkaline phosphatase in liver plasma membrane 
and serum
The pH-dependence of the p-nitrophenylphosphatase in plasma 
membrane fragments was examined using five different buffers. The 
results are shown in Fig. III-26(a). The results with tris and 
glycylglycine show a pattern which suggests an optimum at a pH of 
around 7.5. There would, however, appear to be a second pH optimum, 
shown most clearly with bicarbonate buffer at a pH of around 10.0.
The results with glycine buffer are difficult to interpret. The 
results obtained with dimethylglutarateJ‘show that there is considerable 
activity at an acid pH. Earlier results in our laboratory (Hinton, 
1970) show that this is not due simply to lysosomal acid phosphatase.
The pH-dependence of alkaline p-nitrophenylphosphatase in rat
serum was determined using four different buffers. The results are
shown in Fig. II1-26(b). All buffers give an optimum pH of around
9,5 although the activity obtained with glycine buffer was much lower
than that obtained with the other buffer employed in this study. It
should be noted that similarity of the changes with pH of serum
alkaline p-nitrophenylphosphatase and 5-nucleotidase suggests that
the two activities are due to a single enzyme. This enzyme is 
++
activated by Mg ions (Fig. III-27) and has a km of 3 mM when 
assayed at pH 9.7 withp-nitrophenylphosphate as substrate 
(Fig* III-28).
FIG. III-26 Activity of alkaline p-nitrophenylphosphatase in
(a) liver plasma membrane fragments 
Qb) normal rat serum
as a function of pH. The buffers employed were as 
follows:
0 --- 0  dimethylglutarate
V--- V tris
A--- a  glycine
O o bicarbonate
■ ■ glycylglycine
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FIG. 111-27 Activity of alkaline p-nitrophenylphosphatase in the
serum of a normal rat as a function of the concentration 
of MgC£2 or EDTA in the assay medium. The assays were 
carried out in a bicarbonate buffer, pH 9.5.
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FIG. 111-28 Estimation of Km of alkaline j9-nitrophenylphosphatase 
by replotting the data from Fig. II-2 according to 
Lineweave-Burk.
. .CHAPTER FOUR
DISCUSSION
IV-1 PURITY AND YIELD OF PLASMA MEMBRANE
(a) Isolation of large sheet fragments of plasma membrane
(i) Normal liver
As discussed in Section II1-2(b), I attempted to separate plasma 
membrane from normal rat liver homogenised in 0.25 M sucrose without 
prior perfusion. The normal methods used in our laboratory (e.g.
Hinton et aL, 1970; Issa, 1976) employ perfused liver. The reason 
for using non-perfused noimal rat liver was to determine whether there
•'•T il
was loss of the plasma membrane fragments as compared with the method 
using perfused rat liver. This is relevant to the isolation of sheets 
of hepatoma plasma membrane because the lack of a main blood vessel 
makes it difficult to perfuse tumours. The marker enzymes, 5’-nucleotidase, 
glucose 6-phosphatase, acid phosphatase and succinate dehydro­
genase were respectively used as indicators of the plasma membrane, 
endoplasmic reticulum, lysosomes and mitochondria.
Comparison with the results of Issa (1976), who used a
centrifugation in an A-XII zonal rotor to fractionate the material 
floated from the whole liver homogenate, suggests that the separation 
with unperfused liver is comparable to that obtained using perfused 
normal rat liver. Assay of the enzymes G-6-pase, acid phosphatase 
and succinate dehydrogenase indicates that the fraction prepared by 
flotation from the whole homogenate contains considerable amounts of 
other organelles such as endoplasmic reticulum, lysosomes and mito­
chondria as well as plasma membrane. In my experiments, the plasma 
membrane fragments were partially separated from the contaminating 
organelles by twice resuspending in 0.25 M sucrose and pelleting in
the bench centrifuge. Issa (1976) purified the plasma membrane 
fragments by centrifugation in an A-XII zonal rotor and hence 
obtained a greater purification in the final step. Thus, it would 
seem that, provided that plasma membranes and erythrocytes are 
separated by flotation, it is possible to prepare plasma membranes 
from the livers of rats homogenised in 0.25.M sucrose without prior 
perfusion of the liver. It would, therefore, appear valid to use a 
similar approach in isolating plasma membrane from hepatoma.
(ii) Hepatoma
As mentioned in ’Aims of this study’, a method for isolating 
purified plasma membrane sheets from the slow growing 'WDA' tumour 
had been developed in this laboratory prior to my studies (Prosper©, 
1975). I have used the same techniques for both the slow growing 
’WDA’ tumour and the faster growing ’UA’ tumour to examine whether 
that method is still applicable following progression of the ’WDA’ 
tumour and whether it is useful for both tumours. The patterns 
obtained for the distributions of protein and marker enzymes during 
preparation of plasma membrane fraction by centrifugation of the 
material floated from homogenates of the slow growing ’WDA’ tumour 
seem identical to those obtained by Prospero (1975). However, with 
the faster growing ’UA’ tumour the pattern is quite distinct. The 
zone of plasma membrane sheets at the region of density 
1.12-1.15 g/ml has fewer plasma membrane fragments, as indicated by 
enzymes such as 5’-nucleotidase, than the slow growing tumour. Both 
the yield and purification of plasma membrane fragments are higher 
for the slow growing tumour than for the fast growing tumour. This 
method is therefore more useful for isolating large sheet fragments 
of plasma membrane from the slow growing tumour. The reasons for
this observation were revealed by examination of the sections of 
’UA.’ and ’WDA’ tumours by electron microscopy, as will be discussed 
in the next section.
(b) Subfractionation of microsomes
As described earlier in Section III-2(c), I separated the plasma 
membrane vesicles, which are recovered in the microsomal fraction of 
hepatoma homogenates, by isopycnic flotation of microsomes in a 
linear sucrose gradient. The distributions through the gradients of 
a number of the commonly used plasma membrane marker enzymes were 
studied. With both ’UA’ and;,WDA' hepatoma, plasma membrane fragments, 
as indicated by 51-nucleotidase, alkaline phosphatase and alkaline 
phosphodiesterase, were separated from endoplasmic reticulum frag­
ments, indicated by glucose-6-phosphatase and from lysosomes indicated 
by acid phosphatase. In contrast to the results with liver microsomes 
(Norris et aL, 1974; Issa et al., 1977a),the distribution of 
5’-nucleotidase was very similar to the distribution of other plasma 
membrane enzymes. With the ’WDA’ tumour, all activities were found 
in a band centred at a density of 1.14 g/ml, which is very similar to 
the isopycnic banding density of the 5’-nucleotidase-rich ’sinusoidal’ 
menforanes in liver homogenate (Norris et al., 1974; Issa et aL, 1977a). 
In the case of the ’UA’ hepatoma, the plasma membrane fragments had 
a lower mean density and the very lowest density fragments appeared 
to be slightly enriched in 5’-nucleotidase and in alkaline 
B-glycerophosphatase.
Assay of marker enzymes does, however, show that the preparation 
of plasma membrane fragments of ’UA’ hepatoma contained as 
contaminants other organelles such as endoplasmic reticulum and 
lysosomes. This observation is confirmed by the results obtained
after fractionation of membrane protein on polyacrylamide gel as 
described in Section III-2(d). The patterns showed a group of five 
bands which, by comparison with the distribution of enzymes, 
originate from the endoplasmic reticulum.
Tabulation of the purification and yield of various marker 
enzymes for both tumours (Tables III-5 and III-6) show that when 
using isopycnic flotation techniques for fractionation of the 
’microsomal' fraction, the fast growing ’UA.’ tumour gave more 
purified plasma membrane fragments than the slow growing ’WDA’ 
tumour. This explanation is consistent with the appearance of the 
plasma membrane in sections of the two hepatomas examined under the 
electron microscope (Section III-2(a)). Sections from the ’WDA’ 
hepatoma showed a region of plasma membrane whose structure 
resembles that of the bile canaliculi in liver cells. No regions 
resembling bile canaliculi were found in the sections of the ’UA’ 
hepatoma. The large sheets of plasma membrane present in liver 
homogenates derive largely from the bile canalicular face of the 
hepatocytes. So, the large sheets of plasma membrane recovered in 
the homogenates of ’WDA’ hepatoma could derive from the region of 
the tumour cells which resembles bile canaliculi.
I have discussed the methods used for the purification of the 
large sheets of hepatoma plasma membrane and the small plasma 
membrane-derived vesicles which are recovered in the microsomal 
fraction. In discussing the results obtained with tumours, it is 
interesting to compare purification and specific activity with those 
obtained with normal liver. My experiments gave lower purification 
for hepatoma plasma membrane than the purification achieved by Issa 
et al. (1977b)with normal liver plasma membrane. This may be due to
tumour cells being smaller than hepatocytes. However, Dnistrian 
et al. (1975) who worked on the Morris 5123 tC hepatoma have also 
reported higher purifications than were obtained in this study.
Thus it is likely that lower purification of tumour plasma membrane 
obtained in the present study may be due to the contamination of 
the plasma membrane preparation by other organelles such as 
lysosomes and endoplasmic reticulum fragments.
Extensive comparison of the enzyme activities displayed by 
plasma membrane isolated from rat liver^  and rat hepatomas was. made 
by Emmelot and Bos (1969). They showed that the alkaline phos­
phatase activity of the hepatoma 484 (using p-nitrophenylphosphate 
as substrate) was higher than that on the liver, while the 
5’-nucleotidase activity of the hepatoma was lower than that of the 
liver. In the present study both tumours show a higher activity for 
the alkaline p-nit rophenylphosphatase than was found in normal liver 
by other workers in this laboratory; this is consistent with those 
results reported by Emmelot and Bos (1969), although I did not myself 
measure alkaline phosphatase in the normal liver plasma membrane 
(Table III-2). Plasma membranes from both hepatomas show significant 
alkaline B-glycerophosphatase activity which is not detected in the 
liver membranes. Similar results were reported by Emmelot and Bos 
(1969).
The activity of 51-nucleotidase in the ’WDA’ hepatoma homo­
genate is similar or lower than that of a liver homogenate, while 
in the ’UA' hepatoma homogenate the activity of 5’-nucleotidase is 
higher than that of liver homogenate. Histochemical studies on 
early transplants of the ’U’ hepatoma by El-Aaser (1965) showed 
that the belts of connective tissue which extend through the tumour are
rich in 5’-nucleotidase. Much less 5’-nucleotidase was detected in 
the tumour cells. Therefore, greater amounts of 5’-nucleotidase in 
the ’UA’ hepatoma homogenate as compared to the liver and 'WDA' 
hepatoma homogenate do not necessarily mean that there is more 
5’-nucleotidase in the plasma membrane of the ’UA’ hepatoma cells.
Recently, it has been reported that two different membrane 
regions are obtained during preparation of liver plasma membrane 
(Wisher and Evans, 1975; Issa et al.,1977a; Ca^ and Evans, 1977).
In the present study it was found that .after homogenisation, the 
plasma membrane of hepatoma cells was recovered in two distinct 
forms, large sheets of membrane and vesicles. Wisher and Evans
(1975) have reported that in the liver the membrane sheets derive 
largely from the bile canalicular face of the hepatocyte and the 
vesicles are derived from the sinusoidal surface. In this study it was 
found, that the ’WDA’ hepatoma gave sheets of plasma membrane and,on 
electron microscopy,was found to possess bile canalicular-like 
regions in the tumour. The ’UA’ hepatoma gave very few sheets of 
plasma membrane and contained no bile canalicular-like regions. It 
is therefore reasonable to assume that the ’sheets’ of plasma 
membrane recovered from the ’WDA’ hepatoma derive, like the sheets 
of plasma membrane in liver homogenate, from the bile canalicular 
face of the cells. Because there are significant amounts of tumour 
plasma membrane in vesicular fom,it becomes necessary to purify the 
microsomal fraction of the plasma membrane when dealing with the 
tumour. This is normally not the approach with liver, because 
sheets of plasma membrane give much higher purification.
IV-2 STUDIES ON MATERIALS DERIVING FROM THE PLASMA MEMBRANE
(a) Enzymes
The fractionation of proteins on Sephadex G-200 depends on the 
molecular weights and shape of the molecules. When the serum of 
’UA’ tumour-bearing rats was fractionated on Sephadex G-200 there 
was a clear peak for 5’-nucleotidase in the fractions corresponding 
to the ’void volume’ of the column, suggesting that a small quantity 
of this enzyme is associated with large complexes with a molecular 
weight of more than one million. There * was no trace of a similar 
peak in the serum of normal rats. Sepharose 4-B was used in an 
attempt to determine the molecular weight of the 5’-nucleotidase- 
carrying material which is excluded from Sephadex G-200. However, 
fractionation of the serum of normal and ’UA' tumour-bearing rats on 
Sepharose 4-B showed no significant differences, in particular no 
peak, corresponding to the material excluded from Sephadex G-200 for 
5’-nucleotidase. As the amount of 5'-nucleotidase activity in the 
complex eluted in the void volume of Sephadex G-200 is rather small, 
it would probably remain undetected if spread over several fractions 
on chromatography on Sepharose 4-B. Due to lack of time I was not 
able to repeat the experiment using large amounts of material.
The only conclusion that can be drawn is that the complex is 
not excluded from Sepharose 4-B and hence has a molecular weight of 
less than 4 x 106. If it were excluded, then one would expect a 
sharp peak of activity, as found with Sephadex G-200. The enzymes 
found in the complex detected by chromatography on Sephadex G-200 
are known to be located in the plasma membrane. Shinkai and Akedo 
(.1972) have reported a similar complex in animals and humans with 
hepatic cancer and presented evidence for the presence of a common
antigenic determinant in the complex and in the plasma membrane of 
the liver. This supports the suggestion that the complex could be 
a fragment of the plasma membrane released from the liver. These 
authors point out that liver tissue is rich in vascular beds which 
may increase the possibility that the plasma membrane of dying 
cells will be released into the blood circulation.
A non-immunological method for examining the surface of the 
51-nucleotidase-containing complex in the serum of tumour-bearing 
rats is suggested by studies on the properties of the enzymes. 
described in Section III-4. Those results showed the effect of a 
variety of buffers of various pH on the 5’-nucleotidase and alkaline 
y -nitrophenylphosphatase in the serum and in liver plasma membrane. 
The similarity of the changes of serum 5'-nucleotidase and alkaline 
j?-nitrophenylphosphatase indicates that the activities are due to a 
single enzyme. The enzymes found in the plasma membrane were, 
however, quite distinct in their properties. Hence, by careful 
choice of assay conditions, it should be possible to distinguish 
between the ’normal’ serum 5’-nucleotidase and any additional 
activity deriving from the plasma membrane of liver or hepatoma 
cells.
(b) Immunological studies
Immunological studies on the serum of ’UA’ and ’WDA’ tumour- 
bearing rats after immunoelectrophoresis against anti-serum showed 
only slight differences as compared with the pattern obtained with 
normal serum, although other experiments (see Section IV-3) show 
that the serum of ’UA’ tumour-bearing rats contains a specific 
protein which does not react with anti-(normal rat serum).
Immunoelectrophoresis against anti-liver plasma membrane does not 
show any qualitative differences in the proteins of normal rat serum 
and the serum of tumour-bearing rats and normal rats, but, as 
explained in Section III-l(b), there are quantitative differences in 
the amounts of proteins ’A ’ and ’B', the two serum components which 
react most strongly with anti-(liver plasma membrane). The area of 
peak ’A ’ is greater than peak ’B’ in the serum of tumour-bearing 
rats, whereas in normal serum this situation is reversed. This is 
interesting in that protein ’A* would appear to be the !a2SB globulin* 
(Saba, 1978) which is involved in the iribn-specific removal of material 
from serum by macrophages.
The serum of ’UA* tumour-bearing rats 
also shows a distinct protein band when fractionated on polyacrylamide 
gel gradient (Section III-l(c)). This is the injury macroglobulin 
which is essentially absent in the normal serum (Fig. III-8). Ganrot 
Q.973) has called this band the a2-acute phase globulin, and Gordon
(1976) has isolated this a 2-macroglobulin from ai-macroglobulin and 
shown that it is immunologically unrelated. Further, the serum of the 
’WDA’ tumour-bearing rat shows a clear band after fractionation on 
polyacrylamide gel gradient and staining for glycoproteins using 
periodic acid and Schiff’s reagent (Fig. II1-9(c)). The molecular 
weight of this protein suggests that it could be a-foetoprotein which 
is reported to be present in some tumours and the serum of tumour- 
bearing animals (e.g. Alexander, 1972; Aoyagi et al., 1977). In any 
case, this band indicates the presence of a tumour-specific protein 
which might be released from the hepatoma plasma membrane. This 
point is discussed in more detail in the next section.
IV-3 CHANGES IN PROTEINS OF TUMOUR-BEARING RATS
Immunoelectrophoresis of the serum of rats bearing the ’UA’ and 
’WDA’ hquatomas against an antisera prepared against the ’UA’ hepatoma 
plasma membrane, shows that there are three proteins in the serum of 
tumour-bearing rats which are either absent from normal rat serum or 
are markedly changed in their properties. The properties of the three 
proteins (marked as ’A ’, ’B’ and ’C’ in Fig. 111-21) have been 
discussed in Section III-3(b). Protein 'A' appears as a double peak 
in all sera but the proportion of the rapidly moving component is 
markedly greater in the serum of tumour-bearing rats than in normal 
rat serum. Protein ’B' appears only in the serum of tumour-bearing 
rats. Protein ’C’ is present only in the serum of 'UA' tumour- 
bearing rats and is absent from the serum of normal and ’WDA’ tumour- 
bearing rats. It is probably identical to the protein in the serum 
of ’UA' tumour-bearing rats which reacts with anti-(’UA’ serum) and 
not with anti-(normal rat serum). This observation confirms that, 
as discussed in the previous section, the serum of ’UA' tumour- 
bearing rats contains one protein which is absent from normal serum.
As shown in Fig. III-23(a) (b), neither protein ’B’nor ’C' react 
with the anti-(liver plasma membrane. Although protein ’B ’ does 
react with anti-(rat serum) the very strong reaction with anti- 
(tumour plasma membrane) suggests that it contains some tumour- 
specific antigenic determinants. This would suggest that protein 
’B' is a complex formed by reaction of material released from the 
tumour with normal serum proteins.
Recently, there have been extensive studies on the immuno­
logical response of the host to a tumour. Investigators have worked 
both on the tumour-specific transplantation antigens (TSTA) and on
proteins such as a-foetoprotein, which are found both in foetal 
cells and tumours but not in adult animals (e.g. Thomson et al., 1973; 
Alexander, 1974; Eccles et al., 1976; Aoyagi et al., 1977; Akeson et 
al., 1977). The tumour specific transplantation antigens (TSTA) are 
defined as antigens that can produce specific rejection of tumour 
grafts by immunised animals (see review of Schmidt-Ullrich and 
Wallach, 1978). They are inferred to be plasma membrane components 
because the immune reactions known to produce tumour rejection must 
take place at the cell surface. The tumour specific antigens appear 
to be proteins never produced by normal animals, even in foetal life.
For example, Schimdt-Ullrich et al. (1977) have reported the presence 
in the plasma membranes of GD 248 cells of at least three antigens 
not detectable in the membranes from the normal cell, which show no 
detectable cross reactivity with embryonic material.
Although it is clear that, at least in experimental animals, 
tumours do display specific antigens which can be recognised by this host, 
the tumours are not rejected. It has been reported (Thomson et al., 1973) that 
the antibody activity in the serum of tumour-bearing animals is 
masked by the release of soluble TSTA which forms antigen-antibody 
complexes with specific antibodies. The suggestion has been made 
that in the presence of excess antigen the migration of immunoblasts 
from lymph nodes may be blocked (Hall and Morris, 1965). However, 
immunoblasts are only one component in the cell-mediated response 
of the host against the tumour; small lymphocytes and macrophages 
are also involved. Thomson et al. (1973) have reported that it is 
possible that the circulating antigen and/or antigen-antibody 
complexes may, by directly interacting with the lymphoid cells or 
macrophages, interfere with their capacity to kill the specific
target tumour cell. Eccles et al. (1976) reported an observation 
that in rats with an HSBPA sarcoma, approximately 108 monocytes/day 
must enter the tumour; normal rats have a turnover rate of around 
3.6 x 106 monocytes/day and therefore to supply the monocytes 
entering the tumour their output has to be vastly increased. . The 
stimulus may be provided by a factor released from the tumour which 
acts on the bone marrow,- or be associated with the immune stimulus 
provided by the tumour-specific antigens. It is clear now that there 
is a factor releasing from the tumour-cell surface.
The results obtained in this study showed some evidence for 
tumour-specific antigens. Since protein 'A' is present in both normal 
rat serum and the serum of tumour-bearing rats, it is not relevant as 
a tumour-specific antigen. As discussed above, protein ’BT, which 
appears in the serum of tumour-bearing rats but is not present in 
the serum of normal rats, although it does react with anti-(normal 
rat serum), may be a complex containing tumour-specific antigens. 
Protein ?C’ which is present in the serum of ’UA.’: tumour-bearing rats 
has many of the properties of a-fetoproteins. The presence of these 
proteins in serum is consistent with the proposition of Alexander 
C.1974), that the rapid shedding of transplantation antigens is a 
characteristic of embryonic cells and tumours. Such shedding of 
antigens also occurs in human cancer, for example Aoyagi et al. (1977) 
have pointed out that a-foetoprotein from foetal serum and from the 
ascites fluid of a patient with hepatoma had very similar structures.
Fractionation of the serum of tumour-bearing rats gave evidence 
for a 5’-nucleotidase-containing complex similar to that reported by 
Shihkai and Akedo (1972). Further examination of the pH curves 
suggests that the activities of the serum alkaline jD-nitrophenyl-
phosphatase and 5’ -nucleotidase are due to a single enzyme and 
excluded material from the Sephadex G-200 column did not show any 
alkaline J>-nitrophenylphosphatase activity. Thus, it would seem 
likely that the high molecular weight of 5’-nucleotidase in the 
serum of tumour-bearing rats is not due to absorption of serum 
5’-nucleotidase on to aggregated material, but derives from some 
other source, possibly the plasma membrane of tumour cells.
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